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ABSTRACT 
Michael L. Wallace: Circuit and neuron type-specific roles for Ube3a in the visual cortex 
(Under the direction of Benjamin D. Philpot) 
 
 Balanced excitation and inhibition is critical for normal circuit function and 
disruptions in excitation-to-inhibition (E/I) balance have been shown to exist in many 
neurological disorders.  One such disorder, autism, has been hypothesized to result 
from genetic and/or environmental insults that cause an E/I imbalance in key neural 
circuits/systems.  Angelman syndrome (AS) is an autism spectrum disorder 
distinguished by severe intellectual disabilities, EEG abnormalities, gait disturbances, 
disrupted sleep patterns, profound language impairment, and seizures.  AS is caused 
by deletions or loss-of-function mutations in the maternally inherited allele of UBE3A. 
Similar to humans with AS, AS model mice lacking the maternal Ube3a allele exhibit 
behavioral changes mirroring the hallmarks of the syndrome, including abnormal EEG 
patterns, elevated seizure susceptibility, and difficulty with movement and balance.  
Seizures are believed to be extreme manifestations of E/I imbalance, therefore we 
hypothesized that there existed an E/I imbalance in cortical circuits in AS model mice. 
 We investigated excitatory and inhibitory neurotransmission in the visual cortex 
and found an inhibitory deficit that may arise from defective presynaptic vesicle cycling 
in multiple interneuron populations.  The inhibitory defect is specific to inputs into 
excitatory neurons as neurotransmission onto inhibitory neurons is normal.  Excitatory 
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neurotransmission onto excitatory neurons are also decreased but to a smaller degree 
leading to an E/I imbalance in cortical circuits.   
 We then sought to determine the neuron type-specific requirements for Ube3a in 
regulating E/I imbalance.  We used mice harboring a conditional Ube3a allele to show 
that deleting Ube3a from all inhibitory neurons resulted in none of the synaptic 
phenotypes observed when Ube3a was deleted from all neurons.  Furthermore, when 
we deleted Ube3a from cortical excitatory neurons we observed only defects in evoked 
inhibition.  These findings suggest Ube3a loss is required both pre and postsynaptically 
for several synaptic phenotypes contributing to E/I imbalance observed in AS model 
mice. 
 Together, these studies identify a synaptic mechanism underlying E/I imbalance 
in cortical circuits and may lead to more effective treatments for seizures in AS.         
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CHAPTER 1: EXCITATORY/INHIBITORY BALANCE IN NEURODEVELOPMENTAL 
DISORDERS 
 
1.1 Introduction 
 The neurodevelopmental disorder autism is characterized by impaired social 
interactions and communication, and by restricted or repetitive/stereotyped behaviors 
(American Psychiatric Association, 2013).   There is no single genetic cause of autism; 
therefore neurobiologists have searched for common neural mechanisms that may 
encompass much of the genetic heterogeneity.  A leading hypothesis suggests that 
autism results from genetic and/or environmental insults that cause an imbalance in the 
excitation-to-inhibition (E/I) ratio in key neural circuits and systems (Rubenstein and 
Merzenich, 2003).  Balance between excitation and inhibition in neural circuits is 
essential for efficient and accurate information transfer and processing.  In highly 
interconnected circuits, excess excitation can lead to seizure or epileptic activity, while 
excess inhibition can halt the exchange and propagation of a signal.  To limit these two 
extremes, powerful homeostatic mechanisms exist to keep the E/I balance in a 
restricted range (Marder and Goaillard, 2006; Turrigiano and Nelson, 2004).  Therefore, 
in order for an E/I imbalance to become manifest, there must be an insult(s) so severe 
that homeostatic mechanisms cannot overcome the initial circuit imbalance or, the insult 
impairs the homeostatic mechanisms directly. 
 In support of the E/I imbalance hypothesis, several mouse models of autism have 
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E/I imbalance in neural circuits (Bateup et al., 2013; Dani et al., 2005; Gibson et al., 
2008; Tabuchi et al., 2007; Wallace et al., 2012).  Also, recent studies have shown that 
disrupting E/I balance alone in cortical circuits can produce social behavior 
abnormalities in mice (Yizhar et al., 2011).  Cortical circuits in particular are believed to 
control the higher order cognitive processes and behaviors several of which are affected 
in autism (Dichter, 2012).  Finally, seizures are commonly comorbid with autism 
diagnosis suggesting an elevated E/I ratio (Leung and Ring, 2013; Tuchman et al., 
2010).  Here I will review the evidence for E/I imbalance in several mouse models of 
autism spectrum disorder with a primary focus on cortical circuits.  Specifically, I will 
discuss Fragile X, Rett, and Angelman syndromes which are all monogenetic 
neurodevelopmental disorders on the autism spectrum.  I will then compare common 
cellular and synaptic mechanisms that lead to E/I imbalance and what may be their 
effects on behavior. 
1.2 Fragile X Syndrome 
 Fragile X syndrome (FXS) is the most common monogenetic form of autism and 
is caused by transcriptional silencing of the FMR1 gene (Bassell and Warren, 2008).  
FMR1 codes for FMRP, a RNA binding protein involved in translational regulation of 
specific target RNAs.  FXS patients are characterized by cognitive and social defects, 
seizures, hypersensitivity and hyperactivity (Hagerman et al., 2009).  Many of these 
characteristics are reproduced in the mouse model for FXS, the Fmr1 knockout (KO) 
mouse (Musumeci et al., 2000; Nielsen et al., 2002; Spencer et al., 2005).  Most of the 
studies I will discuss here were performed on male Fmr1 knockout mice (Fmr1-/y), which 
lack Fmr1 from all neurons (Bakker et al., 1994).   
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 Defects in excitatory synaptic structure and transmission were some of the first 
synaptic defects to be described in Fmr1 KO mice (Bureau et al., 2008; Comery et al., 
1997; Nimchinsky et al., 2001).  L5 pyramidal neurons have supernumerary spines in 
Fmr1 KO mice and they are also longer than spines from controls (Comery et al., 1997).  
It is hypothesized that long, thin spines arise from excessive long-term depression in 
Fmr1 KO mice, while increased spine density maintains hyperconnectivity and circuit 
hyperexcitability (Huber et al., 2002).  Additionally, regulation of excitatory synapse 
strength and number was shown to be cell autonomous, regulated by FMRP in the 
postsynaptic pyramidal neuron (Pfeiffer and Huber, 2007).  Elegant paired 
electrophysiological recordings went on to show that excitatory inputs onto fast-spiking 
inhibitory interneurons were weaker in Fmr1 KO leading to deficient recruitment of 
inhibition in the cortex (Gibson et al., 2008).  Furthermore, defects in excitatory inputs 
were due to a cell-autonomous decrease in multivesicular release (Patel et al., 2013).   
 Defects in excitatory transmission likely lead to abnormally long periods of 
increased cortical network activity or “UP states” observed both in vitro and in vivo in the 
Fmr1 KO (Goncalves et al., 2013; Hays et al., 2011).  Moreover, in vivo, within an UP 
state the network was more synchronous in Fmr1 KO mice indicating a developmental 
delay in cortical desynchronization, likely reflecting weak engagement of the inhibitory 
network (Goncalves et al., 2013; Paluszkiewicz et al., 2011).  Therefore, through in vitro 
and in vivo electrophysiology there is strong evidence for E/I imbalance in cortical 
circuits in Fmr1 KO mice.  In support of an E/I imbalance favoring excitation, Fmr1 KO 
mice exhibit robust seizure activity (Yan et al., 2004).  Audiogenic seizures, a model of 
generalized seizure, are the most common method used to evoke seizures in this model 
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and audiogenic seizures are present on FVB, C57BL/6J, and hybrid backgrounds 
(Osterweil et al., 2013; Ross and Coleman, 2000; Yan et al., 2004).  Together, 
accumulated evidence suggest FXS mouse models show a strong E/I imbalance in 
cortical circuits that likely contributes to defects in cortical processing, seizures, and 
cognitive dysfunction.   
1.3 Rett Syndrome 
 Rett syndrome (RTT) is a postnatal neurodevelopmental disorder that affects 
predominately girls (Chahrour and Zoghbi, 2007).  The causative gene, MECP2, is X-
linked and results in mosaicism for the MECP2 mutation in affected girls (Amir et al., 
1999).  MECP2 codes for MeCP2 a transcription repressor that recognizes and binds 
methylated DNA (Lewis et al., 1992).  Decreased levels of MeCP2 results in 
dysregulation of MeCP2 target genes and the onset of RTT symptoms at 6 to 18 
months (Nomura, 2005).  Prominent features of RTT include stereotypies, ataxia, 
seizures, autonomic dysfunction and intellectual disability.  Several mouse models of 
RTT (Mecp2 knockout mice) have been generated and recapitulate many of the 
behaviors seen in humans including hypoactivity, seizures, ataxia, early death and 
learning and memory impairments (Chahrour and Zoghbi, 2007).  Most of the studies I 
will discuss here were performed on male Mecp2 knockout mice (Mecp2-/y) which lack 
Mecp2 from all neurons (Chen et al., 2001).     
 Mecp2 knockout mice have been reported to have an E/I imbalance in cortical 
circuits in several studies (Chao et al., 2010; Dani et al., 2005; Durand et al., 2012).  
This imbalance strongly favors inhibition and is likely to contribute largely to cognitive 
and perceptual impairments in Mecp2 knockout mice.  Decreased excitatory and 
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increased inhibitory neurotransmission was first described in L5 pyramidal neurons of 
primary somatosensory cortex of Mecp2 knockout mice.  This was shown to lead to 
decreased spontaneous action potential firing in vitro and decreased connectivity of 
excitatory circuits (Dani et al., 2005; Dani and Nelson, 2009).  In addition, it is likely that 
decreased excitation in cortex arises from reduced numbers of excitatory synapses as 
spine densities have been shown to be reduced in multiple brain regions in Mecp2 
knockout mice (Fukuda et al., 2005; Stuss et al., 2012).   
 Recent studies using laser scanning photostimulation in primary motor cortex 
have shown decreased excitatory connectivity may be due to loss of Mecp2 in the 
postsynaptic neurons alone.  Mapping of excitatory inputs demonstrated that knocking 
down Mecp2 in a sparse population of L2/3 pyramidal neurons resulted in decreased 
ascending excitatory inputs from L3 and L5A onto knockdown neurons, but not 
neighboring controls (Wood et al., 2009).   
 The first in vivo evidence of E/I imbalance favoring inhibition came from studies 
of neuronal firing patterns in L2/3 of visual cortex (Durand et al., 2012).  In vivo 
recordings from multiunit electrodes showed that both spontaneous and evoked spiking 
rates were reduced in Mecp2 knockout mice leading to a change in signal-to-noise ratio.  
Interestingly, studies in the visual cortex indicate increased inhibition from parvalbumin 
(PV) containing inhibitory neurons is the primary contributor to E/I imbalance due to 
increased PV+ puncta in Mecp2 knockout mice (Durand et al., 2012).  Details 
concerning the underlying functional synaptic defect at inhibitory synapses in Mecp2 
knockout mice remain to be investigated.   
 Collectively, Mecp2 loss in all neurons results in an E/I imbalance that favors 
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inhibition and reduced cortical firing rates, however, depending on the cortical region 
(S1, M1, or V1) the underlying synaptic cause may differ.  Therefore, it was particularly 
surprising when it was shown that deleting Mecp2 in only GABAergic neurons using an 
Mecp2 floxed allele was sufficient to produce all of the behavioral phenotypes observed 
in the Mecp2 knockout mice (Chao et al., 2010).  Additionally, mice where Mecp2 was 
deleted from only GABAergic neurons showed decreased inhibition, but no change in 
excitation onto L2/3 pyramidal neurons in S1.  These findings demonstrate that deleting 
Mecp2 from inhibitory neurons alone results in completely different inhibitory synaptic 
phenotypes than deletion of Mecp2 in all neurons.  It also raises questions concerning 
how homeostatic/compensatory mechanisms may contribute to synaptic abnormalities 
seen in Mecp2 knockout mice.  These data suggest that defective cortical excitatory 
neurotransmission may not be a requirement for any of the RTT behavioral phenotypes 
to manifest.  It will be of great interest to assay inhibitory and excitatory inputs onto 
GABAergic neurons in mice where Mecp2 is deleted in only GABAergic neurons as it 
will give a clearer picture of E/I balance in the circuit/network.  Clearly, the precise 
contribution of disrupted E/I balance to RTT behavioral phenotypes is complex and will 
require more subtle manipulation of Mecp2 in both excitatory and inhibitory neurons to 
fully clarify the contribution of Mecp2 to excitatory and inhibitory synapse function.    
1.4 Angelman Syndrome 
 Angelman syndrome (AS) is a severe neurodevelopmental disorder 
characterized by cognitive disability, seizures, absence of speech, and high comorbidity 
with autism (Williams et al., 2006).  Maternal deletions of chromosome 15q11-q13 and 
mutations specific to UBE3A, which lies within that region, cause AS (Kishino et al., 
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1997).  UBE3A is imprinted and expressed exclusively from the maternally inherited 
chromosome in both humans and mice (Rougeulle et al., 1997).  Interestingly, Ube3a 
seems to be exclusively imprinted in neurons where strong repression of the paternal 
allele occurs postmitotically (Judson et al., 2013).  Glia and other tissues express 
Ube3a biallelically and the effect of maternal Ube3a deletion on these cells is unknown  
(Judson et al., 2013).  However, it is important to note that mice that lack Ube3a from 
the paternal allele (Ube3am+/p-) and are therefore heterozygous for Ube3a in glia and 
other tissues but have normal levels of Ube3a in neurons present no observable 
behavioral phenotypes compared to controls, indicating that loss of Ube3a in neurons is 
required for AS phenotypes (Jiang et al., 1998; Miura et al., 2002).  Ube3a has several 
known functions, one as an E3 ubiquitin ligase that targets substrate proteins and marks 
them for proteosomal degradation (Scheffner et al., 1993), and the other as a 
transcriptional co-activator functioning primarily in the nucleus (Kuhnle et al., 2013; 
Ramamoorthy and Nawaz, 2008).  However, the extent to which Ube3a acts in either or 
both of these capacities in neurons is largely unknown (Mabb et al., 2011).  A mouse 
model of AS was generated in 1998 harboring a Ube3a null allele on the maternally 
inherited chromosome (Jiang et al., 1998).  It recapitulates the major phenotypes seen 
in AS including ataxia, motor dysfunction, seizures, and cognitive disabilities (Jiang et 
al., 1998). 
 Ube3a null mice were first recognized to have defects in excitatory 
neurotransmission in the cortex with the report of reductions in dendritic spine density in 
L2/3 and L5 pyramidal neurons (Sato and Stryker, 2010; Yashiro et al., 2009).  
Spontaneous excitatory neurotransmission was also found to be reduced in Ube3a null 
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mice indicating a functional loss of excitatory synapses in L2/3 pyramidal neurons of V1 
(Yashiro et al., 2009).  Additionally, it was found that the Activity-regulated cytoskeleton-
associated protein (Arc), a protein involved in AMPA receptor internalization, was 
increased in Ube3a null mice, providing a possible molecular mechanism underlying 
reduced excitatory synapse number (Greer et al., 2010).   
While multiple studies reported decreased excitatory connectivity, Ube3a null 
mice have seizures that have been detected with cortical EEG/ECoG recordings, 
suggesting that epileptic activity, at a minimum, spreads to the cortex (Jiang et al., 
1998; Miura et al., 2002).  Therefore, we began an investigation to determine if cortical 
inhibition was altered in Ube3a null mice (Wallace et al., 2012).  We found that both 
spontaneous and evoked inhibitory neurotransmission was reduced onto L2/3 pyramidal 
neurons.  Conversely, both excitation and inhibition onto PV+ inhibitory neurons was 
normal in Ube3a null mice compared to controls.  Defects in inhibitory 
neurotransmission seemed to be due, at least in part, to defects in synaptic vesicle 
cycling.  This was supported by anatomical methods showing increases in clathrin-
coated vesicles specifically at inhibitory axon terminals in Ube3a null mice, compared to 
controls.  Electrophysiological recordings then determined that synaptic recovery from 
high frequency stimulation did not return to control levels at inhibitory synapses in 
Ube3a null mice (Wallace et al., 2012).  We concluded from these studies that there 
existed an E/I imbalance in the cortex favoring excitation that would permit seizure 
propagation and hyperexcitability. 
 Having identified a circuit with E/I imbalance we then sought to determine the 
neuron type specific requirements of Ube3a loss for these synaptic phenotypes.  In 
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order to manipulate Ube3a in neuron class specific manner we generated a conditional 
Ube3a knockout mouse (Ube3aFlox).  We then crossed this mouse line with lines 
expressing Cre in either GABAergic neurons (Gad2-Cre) or pyramidal neurons (NEX-
Cre).  Surprisingly, we saw no synaptic defects when we deleted Ube3a in GABAergic 
neurons, and only detected defects in evoked inhibition when we deleted Ube3a from 
pyramidal neurons.  We conclude that for many of the synaptic phenotypes observed in 
AS model mice, Ube3a loss is required both pre and postsynaptically to cause the 
synaptic defect and resulting E/I imbalance. 
1.5 Common mechanisms of E/I imbalance in autism  
 In each of the mouse models reviewed above there exists an E/I imbalance in 
cortical circuits.  In both Fragile X and Angelman syndrome mouse models this 
imbalance favors excitation, while in Rett syndrome mouse models the balance is tipped 
towards inhibition (Dani et al., 2005; Durand et al., 2012; Patel et al., 2013; Wallace et 
al., 2012).  Therefore, while all mouse models exhibit E/I imbalance, the underlying 
synaptic mechanisms in each model differ significantly. It is important to note that all of 
the reports of E/I imbalance in these mouse models arise from assaying excitatory and 
inhibitory neurotransmission onto excitatory and inhibitory neurons.  Changes in intrinsic 
excitability can also strongly alter E/I balance and have been reported in these mouse 
models, but have yet to be rigorously tested in multiple cell classes in cortex (Dani et al., 
2005; Gibson et al., 2008; Routh et al., 2013; Wallace et al., 2012).  Additionally, 
investigators have focused on different cortical layers and microcircuits in these different 
mouse models (L2/3 for AS, L4 for FXS, and L5 for RTT) further complicating direct 
comparisons.   
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 However, similarities in the synaptic defects leading to E/I imbalance do exist.  In 
all three mouse models significant defects in excitatory neurotransmission are present 
resulting in decreased excitatory-to-excitatory connectivity (Bureau et al., 2008; Dani et 
al., 2005; Yashiro et al., 2009).  In Mecp2 knockout mice decreased excitation is 
accompanied by an increase in inhibition resulting in a “silent” cortex (Dani et al., 2005; 
Durand et al., 2012).  Conversely, excitatory-to-inhibitory connections in Fmr1 knockout 
mice are decreased leading to a reduction in inhibitory activity and a hyperexcitable 
circuit exhibiting increased local network activity (Goncalves et al., 2013; Patel et al., 
2013).  Finally, in Ube3a maternal null mice inhibitory-to-excitatory connections are 
themselves impaired due to defective synaptic vesicle cycling (Wallace et al., 2012).  
The precise impact that the synaptic defects in the Ube3a maternal null mice have on 
local network excitability in vivo remain unknown.  Together, it seems that inhibition, 
rather than excitation, determines whether the E/I ratio favors excitation (Fmr1 KO and 
Ube3a KO) or inhibition (Mecp2 KO).  Obviously, the autism community would benefit 
greatly from comparative studies of the mouse models discussed here.  For example, 
would local network activity (UP/DOWN states) correlate the direction of E/I imbalance 
in different mouse models?  If so, one would expect network activity to be modulated in 
the same direction as FXS in AS, and in the opposite direction in RTT.  Studies 
examining such processes in multiple mouse models may help draw more parallels 
between the effects of synaptic E/I imbalance on local network activity and eventually 
behavior.        
 While excitatory and inhibitory synaptic defects have been observed in these 
mouse models of neurodevelopmental disorders, major unanswered questions 
 11 
 
 
regarding the relationship between inhibitory and excitatory synaptic defects are only 
now beginning to be addressed.  Studies employing conditional knockout mouse lines 
are particularly useful in determining cell class-specific or cell-autonomous synaptic 
defects.  Surprising results in both the Fragile X and Rett syndrome fields have already 
exposed the importance of conditional manipulations of the gene of interest (Chao et al., 
2010; Patel et al., 2013).  Conditional manipulations of gene expression are of particular 
importance in these mouse models as they may help circumvent the indirect effects 
seizure activity can have on synaptic transmission and homeostatic processes (Cossart 
et al., 2001; Kumar and Buckmaster, 2006; Sloviter, 1987).  The development of 
conditional Ube3a mouse lines, as well as more selective and precise temporal and 
regional manipulations of Fmr1 and Mecp2, is sure to elucidate the complex role for 
these genes in synaptic transmission, plasticity, and E/I balance.    
1.6 Outcomes of E/I imbalance in cortical circuits 
While it is clear that E/I imbalance exists in several mouse models of 
neurodevelopmental disorders, major questions remain concerning the actual impact E/I 
imbalance has on the autistic like behaviors.  With the advent of optical and chemical 
genetic means of circuit activity manipulation these questions may finally be able to be 
addressed.  For example, if a synaptic imbalance exists, such as in Mecp2 knockout 
mice, where cortical circuits are hypoexcitable, and a cortical computation, such as 
orientation tuning in the visual cortex, is defective, does restoring optimal excitability in 
the circuit rescue defects in the cortical computation (Durand et al., 2012)?  
Optogenetics allow modulation of E/I balance in real-time, and when combined with 
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quantitative imaging and behavioral techniques, direct relationships between E/I 
balance and behavior can begin to be tested (Guo et al., 2014; Yizhar et al., 2011).   
Seizures have one of the highest comorbidities with autism and are often 
described as extreme manifestations of E/I imbalance (Tuchman et al., 2010).  Seizure 
activity is almost always recorded using scalp EEG, whose signal comes from upper 
cortical layers (Buzsaki et al., 2012).  However, how cortical E/I balance affects seizure 
susceptibility has never been directly tested.  Clearly, cortical circuit imbalance in autism 
is permissive to cortical seizure activity, but whether it is the source remains an open 
question.  In order to understand seizure susceptibility in autism, the relevant circuits 
must be identified first, then more detailed analysis of those circuits will provide insights 
into the relationship between E/I balance autism and seizures.  Finally, when the 
primary underlying circuit defect is well understood, and the impact of rescuing E/I 
imbalance is realized, more precise effective strategies for treatment of E/I imbalance in 
patients with neurodevelopmental disorders will result.          
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CHAPTER 2: MATERNAL LOSS OF UBE3A PRODUCES AN 
EXCITATORY/INHIBITORY IMBALANCE THROUGH NEURON TYPE-SPECIFIC 
SYNAPTIC DEFECTS1 
2.1 Overview 
 Angelman syndrome (AS) is a neurodevelopmental disorder caused by loss of 
the maternally inherited allele of UBE3A.  AS model mice, which carry a maternal 
Ube3a null mutation (Ube3am-/p+), recapitulate major features of AS in humans, 
including enhanced seizure susceptibility.  Excitatory neurotransmission onto 
neocortical pyramidal neurons is diminished in Ube3am-/p+ mice, seemingly at odds with 
enhanced seizure susceptibility.  We show here that inhibitory drive onto neocortical 
pyramidal neurons is more severely decreased in Ube3am-/p+ mice.  This inhibitory 
deficit follows the loss of excitatory inputs and appears to arise from defective 
presynaptic vesicle cycling in multiple interneuron populations.  In contrast, excitatory 
and inhibitory synaptic inputs onto inhibitory interneurons are largely normal.  Our 
results indicate that there are neuron type-specific synaptic deficits in Ube3am-/p+ mice 
despite the presence of Ube3a in all neurons.  These deficits result in 
                                                          
 
1
 This chapter was previously published with Alain C. Burette, Richard J. Weinberg,  
and Benjamin D. Philpot in Neuron (2012) June; 7;74(5):793-800. 
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excitatory/inhibitory imbalance at cellular and circuit levels and may contribute to 
seizure susceptibility in AS.   
2.2 Introduction 
Angelman syndrome (AS) is characterized by severe intellectual disabilities, EEG 
abnormalities, gait disturbances, disrupted sleep patterns, profound language 
impairment, and autism (Williams et al., 2006).  Seizures are present in 90% of AS 
patients, significantly impacting their quality of life and that of their caregivers (Thibert et 
al., 2009).  AS is caused by deletions or loss-of-function mutations in the maternally 
inherited allele of UBE3A (Rougeulle et al., 1997).  UBE3A encodes an E3 ubiquitin 
ligase that, in the brain, is expressed primarily from the maternal allele as a result of 
neuron-specific imprinting (Albrecht et al., 1997).  Similar to humans with AS, mice 
lacking maternal Ube3a (Ube3am-/p+) have abnormal EEG activity and are susceptible to 
cortical seizures, suggesting that loss of Ube3a might disrupt the excitatory/inhibitory 
balance in the neocortex (Jiang et al., 1998).  
 Loss of maternally inherited Ube3a results in decreased excitatory synaptic drive 
onto pyramidal neurons in layer 2/3 (L2/3) of neocortex, as evidenced by a loss of 
dendritic spines (Yashiro et al., 2009).  Decreased Ube3a-mediated proteasomal 
degradation of Arc and Ephexin5 proteins may lead to excitatory synaptic defects 
(Greer et al., 2010; Margolis et al., 2010).  These observations suggest a mechanism 
for how the loss of Ube3a may cause fewer and/or weaker excitatory synapses.  While 
these deficits may be relevant to cognitive phenotypes in Ube3am-/p+ mice, they would 
not on their own predict hyperexcitability and increased seizure susceptibility.  We 
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hypothesized that Ube3a loss results in more severe inhibitory deficits, with the net 
outcome favoring cortical hyperexcitability.  
 Here, we use the visual cortex as a model to study the role of Ube3a in the 
establishment and function of inhibitory circuits.  We show that Ube3am-/p+ mice have an 
abnormal accumulation of clathrin-coated vesicles at inhibitory axon terminals, 
indicating a defect in vesicle cycling.  Consistent with this observation, inhibitory 
synaptic transmission onto L2/3 pyramidal neurons recovers slower following vesicle 
depletion in Ube3am-/p+ mice, compared to wildtypes.  Recovery following high-
frequency stimulation of excitatory synapses onto L2/3 pyramidal neurons, however, is 
normal.  This discrepancy among synapse types may further contribute to 
excitatory/inhibitory imbalance during high levels of activity.  Finally, we show that 
synaptic inputs onto inhibitory neurons in Ube3am-/p+ mice are largely normal.  We 
conclude that neuron type-specific synaptic deficits likely underlie neocortical 
excitatory/inhibitory imbalance in AS.   
2.3 Results 
2.3.1 Inhibitory Deficits in Mature Ube3am-/p+ Mice 
 An excitatory/inhibitory imbalance in AS could arise from reduced numbers of 
inhibitory interneurons, abnormal inhibitory connectivity, and/or decreased inhibitory 
neurotransmission.  To test the first possibility, we performed immunohistochemistry for 
three markers – parvalbumin, calretinin, and somatostatin – which together label 96% of 
the total GABAergic interneurons in L2/3 of mouse primary visual cortex (V1) (Gonchar 
et al., 2007).  We compared Ube3am-/p+ mice  and their wildtype (WT) 129Sv/Ev strain 
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littermate controls at postnatal day 80 (P80), an age where AS model mice exhibit 
abnormal EEG patterns and are susceptible to seizures (Jiang et al., 1998).  We found 
no differences in the density of inhibitory interneurons expressing these markers (Fig. 
2.1A-B), implying that the relative number of inhibitory interneurons is normal in L2/3 of 
V1.  
 Next we investigated the strength and number of inhibitory synapses onto L2/3 
pyramidal neurons.  Using whole-cell voltage-clamp, we recorded miniature inhibitory 
postsynaptic currents (mIPSCs) in the presence of tetrodotoxin to gauge spontaneous 
inhibitory synaptic activity onto excitatory L2/3 pyramidal neurons.  We recorded 
mIPSCs at two ages: P25, during the critical period for ocular dominance plasticity and 
when excitatory deficits have been observed previously, and P80, when the visual 
cortex is fully mature.  We observed no difference in mIPSC amplitude between WT and 
Ube3am-/p+ mice at either P25 or P80, suggesting that the loss of Ube3a did not change 
the strength of inhibitory synapses (Fig. 2.1D; Table 2.1).  While we saw no genotypic 
differences in mIPSC frequency at P25, L2/3 pyramidal neurons in Ube3am-/p+ mice had 
a reduction in mIPSC frequency by P80 (Fig. 2.1E).  These observations indicate that 
the loss of Ube3a leads to fewer functional inhibitory synapses, or a reduction of their 
release probability onto L2/3 pyramidal neurons.     
 To further investigate the development of inhibitory inputs onto L2/3 pyramidal 
neurons, we recorded evoked inhibitory postsynaptic currents (eIPSCs) using L4 
stimulation at different intensities in P25 and P80 Ube3am-/p+ and WT mice (Fig. 2.1F).  
This type of stimulation activates diverse inhibitory inputs and, with strong stimulation, 
can activate most of the inhibitory inputs onto L2/3 pyramidal neurons (Morales et al., 
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2002).  We saw no significant difference in eIPSC amplitude at P25 (Fig. 2.1G), but a 
large decrease in eIPSC amplitude at P80 in Ube3am-/p+ mice compared to WT (Fig. 
2.1H).  Together, these results confirm that there is a severe deficit in the amount of 
inhibition arriving onto L2/3 pyramidal cells in the mature visual cortex of Ube3am-/p+ 
mice.   
 In principle, a decrease in eIPSC amplitude could arise from reductions in the 
number of postsynaptic GABA receptors, a decrease in the release probability of 
inhibitory axon terminals, fewer functional inhibitory synapses, or a depolarized 
inhibitory interneuron action potential threshold.  It is unlikely that the decrease in eIPSC 
amplitude at P80 is due to a decrease in the number of GABA receptors at active 
synapses, since the amplitude of mIPSCs was similar in Ube3am-/p+ and WT mice.  To 
assess whether the decrease in eIPSC amplitude is due to the loss of functional 
synapses or to a decrease in release probability, we examined the paired-pulse ratio of 
inhibitory inputs.  Specifically, we stimulated L4 at varying inter-pulse intervals to evoke 
IPSCs in L2/3 pyramidal cells, and compared the paired-pulse ratio in WT and 
Ube3am-/p+ mice.  We observed no difference in the paired-pulse ratio between 
genotypes at either P25 or P80, implying that release at functional inhibitory inputs onto 
L2/3 pyramidal cells is normal in response to brief stimuli given at several interpulse 
intervals (Fig. 2.1I).  Finally, we found no difference in the action potential threshold or 
intrinsic excitability of FS neurons (a major class of inhibitory interneurons) in Ube3am-/p+ 
mice compared to WT, indicating that reduced eIPSC amplitude is unlikely to be due to 
reductions in evoked action potentials in inhibitory interneurons (Fig. 2.2A-B).  By 
exclusion, our data suggest a reduction in the total number of functional inhibitory 
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synapses.   
2.3.2 Neuron type-specific Reduction in Functional Synapses in Ube3am-/p+ Mice 
 Our previous observations of reduced inhibition were made in Ube3am-/p+ mice on 
the 129Sv/Ev strain, which are susceptible to spontaneous seizures (Jiang et al., 1998), 
making it difficult to determine whether the synaptic abnormalities were a cause or 
result of seizures (Sloviter, 1987).  To address this concern, we tested for possible 
synaptic deficits in Ube3am-/p+ mice maintained on the C57BL/6J strain, which have a 
low incidence of evoked seizures and no reported spontaneous seizures (Jiang et al., 
1998).  We performed mIPSC recordings at P80 in WT and Ube3am-/p+ C57BL/6J mice 
to test if synaptic defects arose in the absence of spontaneous seizures.  As before, we 
observed no genotypic differences in the amplitude of mIPSCs, but a large decrease in 
mIPSC frequency in Ube3am-/p+ mice (Fig. 2.3A).  We also performed mEPSC 
recordings in L2/3 pyramidal neurons in mice on the C57BL/6J strain to confirm 
previous results from the 129Sv/Ev strain (Yashiro et al., 2009).  Consistent with 
previous results, there was a significant decrease in mEPSC frequency, but not 
amplitude, between Ube3am-/p+ and WT mice (Fig. 2.3B).  These observations reveal 
that Ube3am-/p+ L2/3 pyramidal neurons have a 50% reduction in spontaneous inhibitory 
synaptic activity, but only a 28% decrease in excitatory synaptic activity.  Additionally, 
intrinsic excitability of L2/3 pyramidal neurons was increased in Ube3am-/p+ mice 
compared to WT (Fig. 2.2C). Together these data suggest that a disproportionate loss 
of inhibition may lead to an excitatory/inhibitory imbalance in Ube3am-/p+ L2/3 pyramidal 
neurons.      
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 Ube3a is expressed by both excitatory and inhibitory interneurons in the cerebral 
cortex (Sato and Stryker, 2010).  Therefore, Ube3a loss might be expected to affect 
both neuron classes.  To assess this possibility, we recorded spontaneous synaptic 
activity in fast-spiking (FS) inhibitory interneurons, which we identified by membrane 
properties, aspinous dendrites, and characteristic high firing rates (Okaty et al., 2009).  
FS inhibitory interneurons in L2/3 were targeted for whole-cell recording at P80, an age 
at which excitatory and inhibitory neurotransmission onto L2/3 pyramidal neurons is 
altered.  In contrast to L2/3 pyramidal neurons, the loss of Ube3a did not affect either 
the amplitude or the frequency of mIPSCs onto FS inhibitory interneurons (Fig. 2.3C).  
Moreover, excitatory connections onto FS inhibitory interneurons appeared normal, as 
Ube3a loss did not alter mEPSC amplitude or frequency (Fig. 2.3D).  Similar to L2/3, 
Ube3a loss did not change the frequency or amplitude of mIPSCs or mEPSCs onto L5/6 
FS inhibitory interneurons (Fig. 2.4A-B).  These results imply that Ube3a loss has 
neuron type-specific synaptic effects.   
2.3.3 Ube3a Loss Results in Inhibitory Deficits from FS Interneurons  
 We examined the effects of Ube3a loss on FS inhibitory interneurons, which 
provide the majority of perisomatic inhibitory input to L2/3 pyramidal neurons (Jiang et 
al., 2010), impart feed-forward and feedback inhibition, and have been implicated in 
seizure susceptibility (Di Cristo et al., 2004).  Despite the challenge of performing paired 
recordings in adult neocortical slices, we were able to investigate synaptic connectivity 
between 83 pairs of L2/3 FS inhibitory interneurons and L2/3 pyramidal neurons in WT 
and Ube3am-/p+ mice at P80 (Table 2.3).   
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 We first analyzed synaptic connectivity from FS inhibitory interneurons to 
pyramidal neurons.  Using current-clamp recordings, we evoked action potentials in FS 
interneurons with depolarizing current injections at 30 Hz, and simultaneously recorded 
the response in pyramidal neurons (Fig. 2.5A).  To measure short-term plasticity we 
normalized the amplitude of the evoked IPSPs to the amplitude of the first IPSP in the 
train.  We observed no change in the short-term plasticity between genotypes (Fig. 
2.5B).  However, the amplitude of the first IPSP between these pairs was significantly 
decreased in Ube3am-/p+ mice, indicating decreased connection strength from FS 
inhibitory interneurons to L2/3 pyramidal neurons (Fig. 2.5C).  We also found a 31% 
decrease in connection probability in Ube3am-/p+ mice compared to WT mice (Fig. 2.5D), 
supporting the conclusion that the decreased IPSP amplitude is likely due to a reduction 
in the number of functional synapses made from FS interneurons to pyramidal neurons.  
Finally, we estimated the average inhibitory drive from FS inhibitory interneurons onto 
L2/3 pyramidal neurons, by calculating the product of connection strength and 
connection probability, finding that inhibitory drive was reduced by 71% in Ube3am-/p+ 
mice compared to WT mice (Fig. 2.5E).    
 To further investigate possible effects of Ube3a loss on synaptic connectivity, we 
examined the connections from L2/3 pyramidal neurons to FS inhibitory interneurons.  
We measured short-term plasticity and found that Ube3am-/p+ mice had increased 
facilitation at synapses from pyramidal neuron to FS interneurons (Fig. 2.6B).  To 
assess connection strength in this pathway, we measured the amplitude of the first 
EPSP evoked in the postsynaptic FS interneuron, detecting no difference between 
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genotypes (Fig. 2.6C).  Finally, we found no genotypic difference in the connection 
probability of L2/3 pyramidal to FS inhibitory interneuron pairs (Fig. 2.6D).   
 These data suggest that, while excitatory connection frequency and strength onto 
L2/3 FS interneurons are unchanged in Ube3am-/p+ mice, excitatory inputs onto FS 
inhibitory interneurons have altered short-term plasticity, potentially leading to defective 
engagement of FS inhibitory interneurons during trains of activity.  The unchanged 
strength of the pyramidal to FS inhibitory interneuron connections in Ube3am-/p+ mice 
was unexpected, since short-term plasticity measurements indicated a change in 
release probability at this synapse.  We conclude that other factors, such as differences 
in calcium buffering, coupling of calcium channels to release machinery, or vesicular 
trafficking, must underlie the observed changes (Atwood and Karunanithi, 2002).  
Together, these experiments identify a specific inhibitory interneuron subtype, FS 
inhibitory interneurons, that is at least partially responsible for the decrease in inhibition 
found in L2/3 pyramidal neurons in the AS model.   
2.3.4 Ube3a Loss Results in Inhibitory Deficits from Non-FS Interneurons  
 L2/3 pyramidal neurons receive inhibition from a variety of inhibitory interneuron 
subtypes (Markram et al., 2004).  To test whether inhibitory deficits in Ube3am-/p+ mice 
could also be ascribed to other types of interneurons, we used agatoxin, a potent 
irreversible antagonist of P/Q-type voltage-gated calcium channels (VGCCs), to block 
release of GABA selectively from FS inhibitory interneurons (Jiang et al., 2010).  
Agatoxin suppressed about 90% of the total eIPSCs in both WT and Ube3am-/p+ mice 20 
minutes after perfusion of the toxin (Fig. 2.5G).  The agatoxin-insensitive portion of the 
eIPSC had an increased latency from stimulation onset and an increased rise time, 
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suggesting that the agatoxin-insensitive inputs targeted the distal dendrites of L2/3 
pyramidal neurons (Fig. 2.6G-H).  Agatoxin-insensitive inputs also had decreased 
paired-pulse depression compared to the total eIPSC, a signature of non-FS inhibitory 
interneurons (Fig. 2.6F) (Gupta et al., 2000).  After agatoxin perfusion, we recorded 
eIPSCs at different stimulation intensities and again found a decrease in the strength of 
inhibitory inputs in the Ube3am-/p+ mice, compared to WT, demonstrating that Ube3a 
loss also affects inputs from non-FS classes of inhibitory interneurons (Fig. 2.5H).      
2.3.5 Ube3am-/p+ mice have Defects in Synaptic Vesicle Cycling  
 Our electrophysiological data suggest that inhibitory deficits in Ube3am-/p+ mice 
result from a loss of functional inhibitory synapses onto L2/3 pyramidal neurons.  
However, a reduction in functional synapses could arise anatomically from fewer 
synaptic contacts, postsynaptically by a loss of functional receptors, or presynaptically 
by a severe depletion of releasable synaptic vesicles rendering a subset of inhibitory 
axon terminals non-functional.  To test for an anatomical correlate to our functional data, 
we used immunohistochemistry to stain WT and Ube3am-/p+ mice for the vesicular GABA 
transporter (VGAT), a marker for the axon terminals of inhibitory interneurons 
(Chaudhry et al., 1998).  We were surprised to see similar densities of VGAT-positive 
puncta in WT and Ube3am-/p+ mice, suggesting no change in the number of inhibitory 
interneuron axon terminals (Fig. 2.8A-C).  However, there remained the possibility that 
some of these axon terminals were nonfunctional.  To explore this possibility, we used 
electron microscopy to examine synaptic structure in WT and Ube3am-/p+ mice.  Post-
embedding immunogold localization of GABA was used to identify inhibitory synapses 
onto somata in L2/3 of V1.  The area of GABA-positive axon terminals and proportion of 
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mitochondria per terminal were not different between WT and Ube3am-/p+ mice (Fig. 
2.7A2-A3).  However, there was a decrease in the number of synaptic vesicles, and a 
large increase in the number of clathrin-coated vesicles (CCVs), in the Ube3am-/p+ mice 
compared to WT (Fig. 2.7A4-A5, 2.8F-G).  We also tested whether the defects we 
observed in inhibitory synapses were generalized to excitatory synapses.  Similar to 
inhibitory synapses, we observed a decrease in the number of synaptic vesicles, but no 
change in the area of excitatory axon terminals or the proportion of mitochondria per 
terminal (Fig. 2.7B1-B4, 2.8D-E).  Finally, we saw little or no decrease in the number of 
CCVs at excitatory synapses between genotypes (Fig. 2.7B5, 2.8D-E).  These data 
suggest a defect in synaptic vesicle cycling in inhibitory synapses of Ube3am-/p+ mice. 
2.3.6 Incomplete Recovery of IPSCs after High-Frequency Stimulation in 
Ube3am-/p+ mice  
 Previous studies examining synaptic vesicle cycling have identified genes whose 
mutation leads to increased numbers of CCVs in axon terminals (Slepnev and De 
Camilli, 2000).  Many of these mutant synapses maintain the ability to release 
neurotransmitter and have normal short-term plasticity; however, during periods of high 
activity these synapses fail to adequately replenish their synaptic vesicle pool, resulting 
in a delayed recovery to baseline levels of transmitter release (Luthi et al., 2001).  
These studies led us to test if inhibitory synapses in the Ube3am-/p+ mice had functional 
deficits similar to other synaptic vesicle cycling mutants.  We applied a train of 800 
stimuli at 10 Hz while recording eIPSCs in L2/3 pyramidal neurons in WT and 
Ube3am-/p+ mice (Fig. 2.7C).  We then decreased the stimulation frequency to 0.33 Hz 
and recorded the recovery phase of the eIPSC (Fig. 2.7C1).  Ube3a loss had no effect 
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on the depletion phase of the eIPSC (Fig. 2.7C2) in agreement with our previous 
experiments examining short-term plasticity (Fig. 2.1I and 2.5B).  However, we found a 
large decrease in the rate and level of recovery of the eIPSC in Ube3am-/p+ mice 
compared to WT (Fig. 2.7C3).  These data are consistent with defects in inhibitory 
synaptic vesicle cycling in Ube3am-/p+ mice.  Specifically, the decrease in recovery of the 
eIPSC, combined with the increase in CCVs, suggests an inability of newly endocytosed 
CCVs to reenter and replenish the synaptic vesicle pool.  These defects may render a 
subset of inhibitory synapses nonfunctional in Ube3am-/p+ mice.    
 Finally, we challenged excitatory synapses with the same high frequency 
stimulation protocol that we used to test inhibitory synapses (Fig. 2.7D1).  Unlike 
inhibitory synapses, Ube3a loss did not have an effect on the recovery of excitatory 
synapses from high-frequency stimulation (Fig. 2.7D3).  Thus, the pronounced 
accumulation of CCVs observed at inhibitory synapses correlates well with the selective 
deficits in the synaptic recovery from high-frequency stimulation.  Moreover, these 
functional data demonstrate that following a high-frequency train of activity a period of 
heightened excitatory/inhibitory imbalance may occur in this circuit.   
2.4 Discussion 
This work represents the first demonstration that maternal loss of Ube3a, as 
seen in individuals with AS, leads to neuron type-specific synaptic deficits.  Our findings 
suggest that loss of Ube3a can result in an excitatory/inhibitory imbalance in the 
neocortex. 
Earlier studies showing decreased excitatory neurotransmission in Ube3am-/p+ 
mice were difficult to reconcile with reports of high seizure susceptibility (Jiang et al., 
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1998; Yashiro et al., 2009).  Our data provides clarification, showing that the loss of 
Ube3a causes a particularly severe decrease in inhibitory input to L2/3 pyramidal 
neurons.  We also report that AS model mice have a synaptic vesicle cycling defect, 
which suggests a basis for this deficit.  The vesicle cycling defects we observe are 
similar to those observed after deletion of the presynaptic proteins synaptojanin 
(Cremona et al., 1999) or endophilin (Milosevic et al., 2011), both which lead to 
increased CCVs at synaptic terminals, and decreased synaptic recovery from high 
levels of activity.  Notably, inhibitory synapses may be particularly sensitive to 
disruptions in vesicular trafficking, due to their enhanced activity and smaller vesicle 
pools (Hayashi et al., 2008).  These results, combined with our functional studies 
describing defective inhibitory synaptic transmission in Ube3am-/p+ mice, suggest a 
means by which a hyperexcitable cortical circuit could arise despite fewer excitatory 
synapses.   
Ube3a is present in both excitatory and inhibitory interneurons in the brain (Sato 
and Stryker, 2010).  Our results showing different synaptic defects onto excitatory and 
inhibitory neurons indicate Ube3a deficiency causes neuron type-specific deficits.  
Since, Ube3a targets its substrate proteins for proteasomal degradation, the 
consequences of Ube3a loss may depend on which substrate proteins are normally 
present in a cell.  This hypothesis is supported by recent work showing that Arc, a 
protein expressed postsynaptically in excitatory but not inhibitory interneurons, is a 
Ube3a substrate (Greer et al., 2010; McCurry et al., 2010).  Thus, the loss of Ube3a is 
expected to cause an inappropriate overexpression of Arc in excitatory neurons without 
affecting inhibitory interneurons.  Given the ability of Arc to influence AMPA receptor 
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endocytosis (Chowdhury et al., 2006), the neuron type-specific expression of Arc could 
partly explain the excitatory synaptic defects observed onto L2/3 pyramidal neurons and 
the lack of effect in FS interneurons.  Conversely, our findings suggest a novel synaptic 
defect in Ube3am-/p+ mice at inhibitory synapses, primarily affecting presynaptic function 
at inhibitory synapses and resulting in fewer functional synapses.  Intriguingly, the 
observed excitatory and inhibitory defects both involve endocytic processes, albeit at 
different sides of the synaptic cleft, suggesting common processes may be involved. 
Altered function of GABA receptors and/or inhibitory interneurons has been 
hypothesized to underlie many of the phenotypes seen in AS (Dan and Boyd, 2003).  
While attention has focused on how defects in GABAergic neurotransmission may relate 
to epileptic phenotypes in AS, abnormalities in inhibition can have wide-ranging 
consequences, including disrupting synaptic plasticity, cortical network oscillations, and 
cortical circuit architecture (Cardin et al., 2009; Hensch, 2005).  For example, FS 
inhibitory interneurons have a critical role in ocular dominance plasticity (Hensch et al., 
1998), which is severely reduced in Ube3am-/p+ mice (Sato and Stryker, 2010; Yashiro et 
al., 2009).  Our finding that inhibitory interneuron to L2/3 pyramidal neuron connections 
are altered in Ube3am-/p+ mice may prove important for understanding the mechanisms 
underlying plasticity and learning defects in AS.  Understanding the specific synaptic 
impairments caused by the global loss of Ube3a may provide insights into the 
intractable nature of seizures found in many individuals with AS.   
Excitatory/inhibitory imbalance has been observed in several genetic disorders 
that meet diagnostic criteria for autism spectrum disorders, including neuroligin-3 
mutation, Fragile X, and Rett syndrome (Dani et al., 2005; Gibson et al., 2008; Tabuchi 
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et al., 2007).  Moreover, excitatory/inhibitory imbalance may be a general 
neurophysiological feature of autism spectrum disorders, contributing to inappropriate 
detection or integration of salient sensory information due to a decreased signal-to-
noise ratio (Rubenstein and Merzenich, 2003).  Our finding that an excitatory/inhibitory 
imbalance may develop in AS due to the loss of functional inhibitory synapses highlights 
the importance of identifying Ube3a substrates in inhibitory interneurons.   
2.5 Materials and Methods 
2.5.1 Animals 
 Ube3a-deficient mice on the 129Sv/Ev background were originally developed by 
Jiang and colleagues (Jiang et al., 1998) and obtained through the Jackson Laboratory 
(Bar Harbor, ME).  Ube3a-deficient mice backcrossed onto the C57BL/6J background 
were obtained from Yong-hui Jiang (Duke University).  Mice of both genders were used 
between P21-28 or P70-90.  Ube3a-deficient mice and WT littermates were obtained by 
crossing a paternal-null heterozygous female (Ube3am+/p- mice) with a WT male, 
resulting in either WT progeny or progeny with loss of Ube3a only on the maternally-
inherited allele (Ube3am-/p+ mice).  Mice on the 129Sv/Ev background were used for 
experiments in Fig. 2.1.  For all other experiments, mice were obtained by crossing 
female Ube3am+/p- mice on a C57BL/6J background with male mice expressing GFP in a 
subset of parvalbumin expressing fast-spiking inhibitory interneurons (Chattopadhyaya 
et al., 2004) (obtained from Jackson Laboratory).  Mice were raised on a 12-h light/dark 
cycle.  All studies were conducted with protocols approved by the University of North 
Carolina at Chapel Hill Animal Care and Use Committee.    
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2.5.2 Coronal Slice Preparation 
 Mice were anesthetized with pentobarbital (40 mg/kg) and decapitated after 
disappearance of corneal reflexes, in compliance with University of North Carolina 
guidelines.  Brains were rapidly removed and immersed in ice-cold dissection buffer (in 
mM: 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 75 sucrose, 10 dextrose, 1.3 
ascorbic acid, 7 MgCl2, and 0.5 CaCl2) bubbled with 95% O2-5% CO2.  Prior to brain 
removal, P70-P90 mice were first intracardially perfused with dissection buffer to better 
preserve neuronal health and visualization.  The visual cortices were dissected and 350 
μm coronal slices were prepared using a vibrating microtome (Leica VT1000S).   Slices 
were allowed to recover for 20 min in a 35º C submersion chamber filled with 
oxygenated artificial cerebrospinal fluid (ACSF) (in mM; 124 NaCl, 3 KCl, 1.25 
NaH2PO4, 26 NaHCO3, 1 MgCl2 2 CaCl2 and 20 glucose) and then kept at room 
temperature for >40 min until use (Philpot et al., 2003). 
2.5.3 Voltage-clamp Recordings 
 To isolate miniature inhibitory postsynaptic currents (mIPSCs), slices were 
placed in a submersion chamber, maintained at 30º C and perfused at 2 ml/min with 
oxygenated ACSF (as described above) containing (in µM): 20 6,7-dinitroquinoxaline-
2,3-dione (DNQX), 100 D,L-2-amino-5-phosphonopentanoic acid (APV), and 0.2 
tetrodotoxin (TTX).  Cells were visualized using a Ziess Axioskop microscope equipped 
with infrared differential interference contrast (IR-DIC) optics.  FS inhibitory interneurons 
were identified by GFP fluorescence in L5/6 or by firing rates (measured before TTX 
application), aspinous dendrites, and membrane properties in L2/3.  Patch pipettes were 
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pulled from thick-walled borosilicate glass (P2000, Sutter Instruments Novato, CA).  
Open tip resistances were between 2.5-5 MΩ when pipettes were filled with the internal 
solution containing (in mM): 2 NaCl, 141 KCl, 1 CaCl2, 10 EGTA, 2 Mg-ATP, 0.3 Na-
GTP, 10 HEPES, 10 Na-phosphocreatine, and 0.025 Alexa-488 or 568 with pH adjusted 
to 7.25 with 1M KOH and osmolarity adjusted to ~295 mOsm by addition of sucrose.  
Voltage-clamp recordings were performed in the whole-cell configuration using patch-
clamp amplifier (Multiclamp 700A, Molecular Devices), and data were acquired and 
analyzed using pClamp 9.2 or 10.2 software (Molecular Devices).  The high internal 
chloride concentration increased the chloride driving force and allowed mIPSCs to be 
more easily resolved at -80 mV.  Pipette seal resistances were > 1 GΩ, and pipette 
capacitive transients were minimized prior to breakthrough.  Changes in series and 
input resistance were monitored throughout the experiment by giving test pulse every 
30 s and measuring the amplitude of the capacitive current.  Cells were discarded if 
series resistance rose above 30 MΩ or series resistance or input resistance changed by 
>25%.   
 For evoked IPSCs, a different internal solution was used to minimize the firing of 
action potentials in the postsynaptic cell when measuring the evoked response.  This 
internal solution contained (in mM): 107 CsOH, 107 D-gluconate, 5 TEA-Cl, 2.7 NaCl, 
20 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 0.2 EGTA, 10 BAPTA, 5 QX-314-Cl and 0.025 
Alexa-488 with pH adjusted to 7.2 with 1M CsOH and osmolarity adjusted to ~300 
mOsm by addition of sucrose.  The ASCF was identical to solution described above, but 
tetrodotoxin was not added.  To increase the driving force for chloride with this internal 
solution, voltage-clamp recordings were performed at 0 mV.  IPSCs were evoked from a 
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stimulating electrode (concentric bipolar; 200 μM tip separation) placed in 150 μm 
ventral of the recorded neuron, and stimulation was delivered for 200 μs.  For agatoxin 
experiments ω-Agatoxin-IVa (Ascent Scientific) was perfused at a concentration of 500 
nM in 0.01% BSA for 10 minutes.  eIPSC latency was calculated as the time from the 
stimulus artifact to the initiation of the IPSC, and the rise time was calculated as the 
time elapsed during the rising phase of the IPSC.      
 mEPSCs were recorded at -70 mV in ACSF containing (in µM) 0.2 TTX, 100 
APV, and 50 picrotoxin.  The internal solution contained (in mM): 100 K-Gluconate, 20 
KCl, 0.2 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 10 HEPES, 10 Na-phosphocreatine and 0.025 
Alexa-488 or 568 with pH adjusted to 7.25 with 1M KOH and osmolarity adjusted to 
~295 mOsm by addition of sucrose.  
 For evoked EPSCs the same internal solution was used as for evoked IPSCs, 
however the cells were held at the reversal potential for chloride (-35 mV).  As an 
additional control 20 μM DNQX was washed on after the depletion and recovery phases 
of the experiment to test for contamination of the EPSC with an IPSC.  If the EPSC did 
not decrease by more than 80% the experiment was not included for analysis.   
2.5.4 Current-clamp Recordings 
 Intrinsic excitability experiments were performed at -70 mV in ACSF with the 
same internal solution used for mEPSC experiments.  Voltage threshold for AP 
generation was determined by measuring when dVm/dt reached 10 V/s.  For frequency-
current curves, current was injected at 40 pA steps and average AP frequency was 
calculated to the same current injection.  Slope was determined at the linear portion of 
the frequency-current curve for each experiment.  The spike adaptation ratio was 
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calculated by dividing the average of the last two inter-event intervals by the first inter-
event interval in the spike train.  Spike trains from 10-20 Hz or 20-100 Hz were 
averaged to calculate the spike adaptation for pyramidal and FS inhibitory neurons 
respectively.  Resting membrane potential (Vm) is given without adjustment for junction 
potential. 
 Paired recordings were performed with the pyramidal neuron maintained at -80 
mV and the inhibitory interneuron maintained at -65 mV for the duration of the 
experiment in ACSF.  Identification of pyramidal and inhibitory neuron cell types was 
determined using morphological and spiking characteristics.  A pair was considered 
connected if the average (>12 trials) peak amplitude of a postsynaptic potential (PSP) 
was >0.3 mV and followed the presynaptic AP by 1-3 ms.  Average PSP amplitudes 
were measured with respect to baseline immediately preceding PSP onset and were 
averages of at least 12 trials.  The internal solution used for paired recordings contained 
(in mM) 134 KCl, 2 NaCl, 10 HEPES,  0.2 EGTA, 10 sucrose, 4 Mg-ATP, 0.3 Na-GTP, 
14 Na-phosphocreatine and 0.025 Alexa-488 with pH adjusted to 7.2 with KOH and 
osmolarity adjusted to ~300 mOsm by addition of sucrose.  A subset of unidirectional 
pyramidal to FS interneuron paired recordings with 4 presynaptic action potentials at 30 
Hz were not included in the short-term plasticity data but were included in the analysis 
of pyramidal-FS connection frequency and strength.      
2.5.5 Immunohistochemistry 
Light Microscopy 
 Histology was performed on visual cortices of ~P80 mice that were intracardially 
perfused with 80 mL of 4% paraformaldehyde (PB, 0.1 M, pH 6.8) and sliced coronally 
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at 40-60 µm on a freezing sliding microtome (Ziess HM430) for Fig. 2.1, or a Vibratome 
for Fig. 2.8.  Slices were then washed in 0.1 M PBS and incubated in 0.1 M tris-glycine 
for 30 min, permeabilized in 0.3% Triton-X and blocked in 10% normal donkey serum 
(Eagleson et al., 2005).  Primary antibodies were incubated overnight at room temp at 
the following concentrations: mouse anti-VGAT 1:1000 (Synaptic Systems), rabbit anti-
parvalbumin 1:250 (Swant), rabbit anti-calretinin 1:200 (Swant), rabbit anti-somatostatin 
1:1000 (Peninsula, Cat# T-4103).  Donkey anti-rabbit secondary antibodies were 
incubated for 1 hr at room temp and mounted on slides.  Primary visual cortex was 
imaged with a 20x objective on a Ziess Axioskop.  For images of Alexa dye-filled cells, 
slices were drop fixed in 4% paraformaldehyde for 1 hr after the termination of a 
recording.  Slices were then mounted on slides and imaged with an Olympus FV1000 
confocal microscope.  Z-stacks were compiled and maximum intensity projections of 
image series were used in figures.  
 For VGAT staining, antigenic sites were visualized with donkey IgG conjugated to 
DyLight 488 (1:200, Jackson ImmunoResearch; West Grove, PA).  Sections were then 
counterstained with Hoechst 33342 (Invitrogen) to visualize all cell nuclei and/or with 
NeuroTrace 640/660 (Invitrogen) to selectively visualize neuronal somata.  Sections 
were examined with an Olympus FV1000 laser scanning confocal microscope. Z-axis 
image stacks were acquired (z-step size 0.6 μm) as 1,024  × 1.024 pixel images, with a 
planapo ×60 objective (numerical aperture 1.42) and pinhole 1.0 Airy unit. To improve 
signal/noise ratio, 16 frames of each image were averaged. To obtain a better signal-to-
noise ratio image stacks were processed using the AMIRA deconvolution algorithm. 
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Quantitative analysis was performed on randomly-selected 51 µm X 51 µm fields from 
layer II/III of primary visual cortex (20 fields per mice, three wild-type and three mutant 
mice) using ImageJ (http://rsb.info.nih.gov/ij/, Rasband, 1997-2011).  Optimal 
visualization of punctate staining (good separation between contiguous puncta, along 
with clear contours for each immunopositive punctum) was achieved by setting the 
threshold to the median pixel value over the field under study. 
Electron Microscopy 
 Mice were intracardially perfused with 0.9% saline solution for 1 min, followed by 
a mixture of depolymerized 2% paraformaldehyde and 2% glutaraldehyde (Electron 
Microscopy Science) in 0.1 M phosphate buffer, pH 6.8.  Brains were removed and 
postfixed overnight in the same fixative. 50 µm-thick sections were cut on a Vibratome, 
incubated 1 hr in 1% osmium tetroxide in 0.1 M phosphate buffer (pH 6.8), rinsed in 0.1 
M maleate buffer (pH 6.0), and incubated in 1% uranyl acetate in maleate. Sections 
were dehydrated in ethanol, infiltrated with Spurr resin, and flat-embedded between 
sheets of ACLAR plastic.  Chips of tissue were cut from heat-polymerized wafers and 
glued to plastic blocks; thin (~70 nm) sections were collected on copper mesh grids and 
poststained with uranyl acetate and Sato’s lead.  
 Postembedding immunocytochemistry was performed as previously described 
(Phend et al., 1992).  Nickel grids were pre-treated using 0.01M citrate buffer (pH 6, at 
60°C for 15 mins) and blocked in 1% bovine serum albumin in Tris-buffered saline with 
0.005% Tergitol NP-10 (TBSN, pH 7.6), then incubated overnight at 21–24 °C with the 
rabbit anti-GABA antibody (Sigma, A2052, 1:100,000). Grids were rinsed, blocked in 1% 
normal goat serum in TBSN (pH 8.2), and incubated in goat anti-rabbit conjugated to 20 
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nm gold particles (BBI, EM.GAR20) for 2 h, rinsed, then counterstained with 1% uranyl 
acetate followed by Sato's lead.  Electron micrographs were collected with a Philips 
Tecnai microscope at 80 KV. 
Analysis 
 Inhibitory and excitatory presynaptic terminals from three wild-type and four 
mutant mice were analyzed (at least 20 terminals per animal for each classes).  
Inhibitory terminals were identified by GABA staining; attention was restricted to 
axosomatic contacts.  Excitatory synapses terminating onto dendritic spines were 
identified by their prominent postsynaptic density. 
 Parameters measured included cross-sectional area of the presynaptic terminal 
and mitochondria within, number of synaptic vesicles, and number of clathrin-coated 
vesicles.  All morphometric analyses were performed by an anatomist blinded with 
respect to genotype.  
2.5.6 Statistics 
 Most experiments and analyses were performed blind to genotype.  Unpaired 
students t-tests were used on all data except input-output, frequency-current, short-term 
plasticity, and connection probability.  For input-output, frequency-current, and short-
term plasticity analyses we employed a 2-way ANOVA to assess significance.  For 
connection probability, we used a chi-squared test and a Fisher’s exact test for 
significance.  For depletion and recovery experiments we used a monophasic non-linear 
regression analysis to assess significance.  The function was as follows:  
Y=(Y0 - Plateau)
-K*X + Plateau 
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Where Y0 is the Y value when time (X) is zero, Plateau is Y at infinite times, and K is the 
rate constant.  Graphs represent the mean and error bars represent the SEM.  For all 
figures p-values are as follows *p<0.05, **p<0.01, ***p<0.001.  All statistics were 
performed in Graphpad Prism.   
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Figure 2.1  Inhibitory synaptic deficits arising through development in Ube3am-/p+ 
mice are not due to decreased density of inhibitory interneurons. 
 (A) Photomicrographs of immunocytochemical markers for inhibitory interneurons 
in visual cortex of wildtype (WT) and Ube3a-deficient (m-/p+) mice. (B) Quantification of 
parvalbumin, calretinin, and somatostatin positive neurons in L2/3 of mouse primary 
visual cortex at ~P80 (n=4 mice/genotype).  (C) Sample mIPSC recordings from ~P25 
(P21-P28) and ~P80 (P70-P90) WT and Ube3am-/p+ mice (scale bar = 30 pA, 400 ms).  
(D) Average mIPSC amplitude was similar between WT and Ube3am-/p+ mice at ~P25 
(WT n=10 cells; m-/p+ n=8 cells) and ~P80 (n=13 cells/genotype) in L2/3 pyramidal 
cells.  (E) Average mIPSC frequency for ~P25 (WT n=10 cells; m-/p+ n=8 cells) and 
~P80 (n=13 cells/genotype) (see also Table 2.1).  (F) Illustration of stimulation (L4) and 
recording (L2/3 pyramidal neuron) configuration in primary visual cortex, and sample 
recordings of evoked IPSCs at stimulation intensities of 0, 10, 30, and 100 µA (scale bar 
= 500 pA, 30 ms).  (G) Evoked IPSCs at ~P25 (WT n=26 cells; m-/p+ n=29 cells) and 
(H) ~P80 (WT n=20 cells; m-/p+ n=14 cells).  (I) Sample recordings of evoked IPSCs in 
paired-pulse experiments (scale bar = 100pA, 20 ms) and quantification of paired-pulse 
ratio in mice aged ~P25 (WT n=12 cells; m-/p+ n=11 cells) and ~P80 (WT n=13 cells; 
m-/p+ n=8 cells.)  (see also Fig. 2.2).  All data are represented as the mean ± SEM; 
**p<0.01, ***p<0.001. 
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Figure 2.2 L2/3 pyramidal neurons, but not FS inhibitory interneurons, have 
increased intrinsic excitability in Ube3am-/p+ mice at P80. 
(A1) Sample responses of a L2/3 FS inhibitory interneuron to current injections 
and (A2) average frequency-current curves from WT and Ube3a
m-/p+ mice (cell was held 
at -70 mV) (WT n=13 cells; m-/p+ n=10 cells; scale bar 20 mV, 40 ms).  (A3) Average 
values (left to right) of frequency-current curve slope (p=0.24), current threshold 
(p=0.69), resting membrane potential (Vm; p=0.28), input resistance (Rin; p=0.95), 
voltage threshold for spiking (p=0.63) and spike adaptation ratio (p=0.11). (B1) Sample 
responses of a L5/6 GFP+ FS inhibitory interneuron to current injections and (B2) 
average frequency-current curves from WT and Ube3am-/p+ mice (cell was held at -65 
mV) (WT n=8 cells; m-/p+ n=11 cells; scale bar 20 mV, 40 ms).  (B3) Average values 
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(left to right) of frequency-current curve slope (p=0.70), current threshold (p=0.81), 
resting membrane potential (Vm; p=0.54), input resistance (Rin; p=0.72), voltage 
threshold for spiking (p=0.38), and spike adaptation ratio (p=0.86).  (C1) Sample 
responses of a L2/3 pyramidal neuron to current injections and (C2) average frequency-
current curves from WT and Ube3am-/p+ mice (cell was held at -70 mV) (WT n=10 cells; 
m-/p+ n=23 cells; p=0.09; scale bar 20 mV, 40 ms).  (C3) Average values (left to right) of 
frequency-current curve slope (p=0.35), current threshold (p=0.02), resting membrane 
potential (Vm;; p=0.85), input resistance (Rin; p=0.08), and voltage threshold for spiking 
(p=0.19).  All bars represent the mean ± SEM; *p<0.05. 
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Figure 2.3 Ube3a loss leads to neuron type-specific defects in inhibitory 
neurotransmission. 
 (A1) Illustration and photomicrograph of a filled L2/3 pyramidal neuron and 
sample recordings from ~P80 WT (upper) and Ube3am-/p+ (lower) mice (scale bar = 40 
pA, 300 ms.)  (A2) Average mIPSC amplitude (n=11 cells/genotype, p=0.16) and (A3) 
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frequency (n=11 cells/genotype) from L2/3 pyramidal neurons.  (B1) Illustration and fill of 
a L2/3 pyramidal neuron and sample recordings from ~P80 WT (upper) and Ube3am-/p+ 
(lower) mice (scale bar 15 pA, 300 ms).  (B2) Average mEPSC amplitude (WT n=6 cells; 
m-/p+ n=9 cells) and (B3) frequency (WT n=6 cells; m-/p+ n=9 cells) from L2/3 
pyramidal neurons.  (C1) Illustration and fill of a L2/3 FS inhibitory interneuron and 
sample recordings from ~P80 WT (upper) and Ube3am-/p+ (lower) mice (scale bar 40 pA, 
300 ms).  (C2) Average mIPSC amplitude (WT n=13 cells; m-/p+ n=10 cells) and (C3) 
frequency (WT n=13 cells; m-/p+ n=10 cells; p=0.57) from L2/3 FS inhibitory 
interneurons.  (D1) Illustration and fill of a L2/3 FS inhibitory interneuron and sample 
recordings from ~P80 WT (upper) and Ube3am-/p+ (lower) mice (scale bar 10 pA, 300 
ms).  (D2) Average mEPSC amplitude (WT n=13 cells; m-/p+ n=12 cells) and (D3) 
frequency (WT n=13 cells; m-/p+ n=12 cells) from L2/3 FS inhibitory interneurons (see 
also Fig. 2.4 and Table 2.2).  Bar graphs represent the mean ± SEM; p*<0.05, 
p***<0.001. 
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Figure 2.4 L5/6 FS inhibitory interneurons do not show changes in mEPSC or 
mIPSC amplitude or frequency at ~P80, L2/3 pyramidal neurons have decreased 
mIPSC amplitude and frequency at ~P40 
(A1) Sample recordings from ~P80 WT (upper) and Ube3a
m-/p+ (lower) mice (scale bar = 
40 pA, 300 ms.)  (A2) Average mIPSC amplitude (WT n=13 cells; m-/p+ n=14 cells; 
p=0.30) and (A3) frequency (WT n=13 cells; m-/p+ n=14 cells, p=0.78) from L5/6 GFP+ 
FS inhibitory interneurons.  (B1) Sample recordings from ~P80 WT (upper) and 
 44 
 
 
Ube3am-/p+ (lower) mice (scale bar = 20 pA, 300 ms).  (B2) Average mEPSC amplitude 
(WT n=8 cells; m-/p+ n=7 cells, p=0.45) and (B3) frequency (WT n=8 cells; m-/p+ n=7 
cells; p=0.69) from L5/6 GFP+ FS inhibitory interneurons (see also Table 2.2).  (C1) 
Sample recordings from ~P40 WT (upper) and Ube3am-/p+ (lower) mice (scale bar = 40 
pA, 300 ms.)  (C2) Average mIPSC amplitude (WT n=12 cells; m-/p+ n=13 cells; p=0.02) 
and (C3) frequency (WT n=12 cells; m-/p+ n=13 cells, p=0.04) from L2/3 pyramidal 
neurons.  Bar graphs represent the mean ± SEM. 
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Figure 2.5  Synaptic deficits arise from both FS and non-FS inhibitory 
interneurons in Ube3am-/p+ mice.   
(A) Recording configuration (left) and representative recordings of presynaptic action 
potentials evoked in a FS inhibitory interneuron (upper), and resulting unitary IPSPs in a 
L2/3 pyramidal neuron (lower) from WT (blue) and Ube3am-/p+ mice (red).  Average is of 
12 trials.  Scale bar “Pre” 20 mV, 40 ms; “Post” 4 mV, 40 ms.  (B) Average short-term 
plasticity of inhibitory to excitatory connections (WT n=8; m-/p+ n=12) (presynaptic 
spikes @ 30 Hz).  (C) Average unitary IPSP amplitude of 1st IPSP of inhibitory to 
excitatory connections (WT n=8; m-/p+ n=12).  (D) Connection probability of FS 
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inhibitory interneurons to L2/3 pyramidal neurons (numbers of connected/total pairs 
written in bars); (E) inhibitory drive of FS inhibitory interneurons to L2/3 pyramidal 
neurons (WT n=19 pairs; m-/p+ n=30 pairs).  (F) Recording configuration (upper) and 
representative recordings (lower) of eIPSCs during baseline (black) and 20 minutes 
after 500 nM ω-agatoxin-IVa perfusion (green) (scale bar = 100 pA, 20 ms).  (G) A 10 
minute baseline was recorded before a 10 minute perfusion of agatoxin (green bar) (WT 
n=10; m-/p+ n=10).  (H) Input-output relationship in the agatoxin-insensitive portion of 
total eIPSC performed 20 minutes after cessation of agatoxin perfusion (WT n=10; 
m-/p+ n=10).  (see also Figure 2.6 and Table 2.3).  Data are represented as the mean ± 
SEM; *p<0.05, **p<0.01, ***p<0.001.     
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Figure 2.6 L2/3 pyramidal to L2/3 FS inhibitory interneuron paired recordings and 
effects of agatoxin on eIPSC short-term plasticity, latency, and rise time.    
(A) Recording configuration (left) and representative recordings of presynaptic action 
potentials evoked in a L2/3 pyramidal neuron (upper), and resulting unitary EPSPs in a 
FS inhibitory interneuron (lower) from WT (blue) and Ube3am-/p+ mice (red).  Average is 
of 12 trials. Scale bar “Pre” 40 mV, 60 ms; “Post” 4 mV, 60 ms.  (B) Average short-term 
plasticity of excitatory to inhibitory connections (WT n=6; m-/p+ n=10; p=0.001) 
(presynaptic spikes @ 30 Hz).  (C) Average unitary EPSP amplitude of 1st EPSP of 
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excitatory to inhibitory connections (WT n=14; m-/p+ n=16; p=0.54).  (D) Connection 
probability of L2/3 pyramidal neurons to FS inhibitory interneurons (numbers of 
connected/total pairs written in bars) and (E) the average excitatory drive of connected 
and non-synaptically connected pairs (WT n=36 pairs; m-/p+ n=47 pairs).  (F) eIPSCs 
normalized to the 1st IPSC in a 4 pulse stimulation train at 20 Hz during baseline period 
and 20 min after perfusion with 500 nM agatoxin (green) (WT n=10; m-/p+ n=10).  (G) 
Increase in latency between stimulus artifact and eIPSC onset after perfusion of 500 nM 
agatoxin (red line shows mean ± SEM) (WT n=10; m-/p+ n=10).  (H) Increase in rise 
time of eIPSC after perfusion of 500 nM agatoxin (red line shows mean ± SEM) (WT 
n=10; m-/p+ n=10).         
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Figure 2.7 Inhibitory synapses of Ube3am-/p+ mice have presynaptic defects. 
(A1) Electron micrographs of inhibitory synapses stained for GABA in ~P80 WT and 
Ube3am-/p+ mice (green denotes axon terminal, blue denotes soma), insets highlight 
CCVs (scale bar = 250 nm).  Average values of (left to right) (A2) axon terminal area, 
(A3) mitochondrial area divided by terminal area, (A4) number of synaptic vesicles per 
square micron, and (A5) number of CCVs per square micron (WT n = 3; m-/p+ n = 4).  
(B1) Electron micrographs of excitatory synapses in WT and Ube3a
m-/p+ mice (green 
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denotes axon terminal, red denotes spine) (scale bar = 250 nm).  Average values of (left 
to right) (B2) axon terminal area, (B3) mitochondrial area divided by terminal area, (B4) 
number of synaptic vesicles per square micron, and (B5) number of CCVs per square 
micron (WT n = 3; m-/p+ n = 4).  (C1)  Sample recordings (left) and sample experiment 
(right) showing baseline (black), high frequency depletion (orange), and recovery (black) 
phases (scale bars; baseline = 200 pA, 20 ms; depletion = 200 pA, 200 ms; recovery = 
200 pA, 20 ms).  (C2) Average depletion phase showing eIPSC amplitude normalized to 
baseline during 800 stimuli at 10 Hz.  10 responses are averaged for each point and a 
monophasic exponential was fit to the averaged responses for WT and Ube3am-/p+ mice 
(WT n=19; m-/p+ n=18).  (C3) Average recovery phase showing eIPSC amplitude 
normalized to baseline during 90 stimuli at 0.33 Hz.  3 responses are averaged for each 
point and a monophasic exponential was fit to the averaged responses for WT and 
Ube3am-/p+ mice (WT n=19; m-/p+ n=18).  (D1)  Sample recordings (left) and sample 
experiment (right) showing baseline (black), high frequency depletion (orange), and 
recovery (black) phases (scale bars; baseline = 100 pA, 10 ms; depletion = 100 pA, 200 
ms; recovery = 100 pA, 10 ms).  (D2) Average depletion phase showing eEPSC 
amplitude normalized to baseline during 800 stimuli at 10 Hz.  10 responses are 
averaged for each point and a monophasic exponential was fit to the averaged 
responses for WT and Ube3am-/p+ mice (WT n=10; m-/p+ n=11).  (D3) Average recovery 
phase showing eEPSC amplitude normalized to baseline during 90 stimuli at 0.33 Hz.  3 
responses are averaged for each point and a monophasic exponential was fit to the 
averaged responses for WT and Ube3am-/p+ mice (WT n=10; m-/p+ n=11) (see also 
Figure 2.8).  Data are represented as the mean ± SEM; *p<0.05, ***p<0.001.      
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Figure 2.8 Quantification of VGAT puncta density and electronmicrographs from 
WT and Ube3am-/p+ mice.  
(A and B) Photomicrographs of immunocytochemical markers of inhibitory interneuron 
terminals (VGAT) in L2/3 visual cortex of WT (A) and Ube3am-/p+  (B) mice, nuclei are 
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stained with Neurotrace (A3 and B3) (scale bar A1 and B1 = 50 μm; A2 and B2 = 15 μm).  
(C) Quantification of VGAT puncta per 100 square microns (n=3 animals/genotype).  (D 
and E) Electron micrographs of excitatory synapses in WT and Ube3am-/p+ mice (green 
denotes axon terminal, red denotes spine) (scale bar = 200 nm).  (F and G) Electron 
micrographs of immunogold staining of GABA used to identify inhibitory synapses onto 
soma (blue) in L2/3 of V1.  CCVs are highlighted with circles (scale bar = 200 nm).   
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Figure 2.9 Inhibitory synaptic depletion and recovery at ~P25 
(A) Average depletion phase showing eIPSC amplitude normalized to baseline during 
800 stimuli at 10 Hz.  10 responses are averaged for each point for WT and Ube3am-/p+ 
mice (WT n=9; m-/p+ n=9).  (B) Average recovery phase showing eIPSC amplitude 
normalized to baseline during 90 stimuli at 0.33 Hz.  3 responses are averaged for each 
point for WT and Ube3am-/p+ mice (WT n=9; m-/p+ n=9). 
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Table 2.1 Membrane properties from mIPSC experiments related to Figure 2.1 
       From Fig. 2.1C, D, E mIPSCs L2/3 Pyramidal Neurons 129Sv/Ev 
  ~P25 ~P80 
  WT m-/p+ p value WT m-/p+ p value 
neuron number 10 8   13 12   
Cm (pF) 113±9.8 126±12.3 0.400 145±5.7 122±6.2 0.007 
Rs (MΩ) 20±1.3 20±0.8 0.910 18±0.8 18±0.6 0.807 
Rm (MΩ) 188±25.3 180±26.9 0.850 84±2.2 124±12.2 0.003 
Tau (ms) 2.3±0.2 2.7±0.3 0.238 2.7±0.1 2.4±0.1 0.015 
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Table 2.2 Membrane properties from mEPSC and mIPSC experiments related        
to Figure 2.3 and 2.4 
     
       From Fig. 2.3A mIPSCs L2/3 Pyramidal Neurons C57BL/6J 
  ~P80 
     WT m-/p+ p value 
   neuron number 11 11   
   Cm (pF) 122±6.1 121±10.9 0.937 
   Rs (MΩ) 21±1.0 21±1.2 0.729 
   Rm (MΩ) 99±6.8 122±11.2 0.093 
   Tau (ms) 2.6±0.1 2.4±0.3 0.560 
    
From Fig. 2.3B mEPSCs L2/3 Pyramidal Neurons C57BL/6J 
    ~P80 
     WT m-/p+ p value 
   neuron number 6 9   
   Cm (pF) 150±8.3 150±8.1 0.989 
   Rs (MΩ) 18±1.6 18±0.8 0.684 
   Rm (MΩ) 86±17.8 72±6.7 0.436 
   Tau (ms) 2.9±0.2 2.5±0.1 0.128 
   
       From Fig. 2.3C mIPSCs L2/3 FS Inhibitory Neurons C57BL/6J 
    ~P80 
     WT m-/p+ p value 
   neuron number 13 10   
   Cm (pF) 42±2.3 39±1.2 0.295 
   Rs (MΩ) 24±1.1 27±1.7 0.105 
   Rm (MΩ) 101±6.8 111±8.8 0.366 
   Tau (ms) .418±0.04 .446±0.03 0.623 
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From Fig. 2.3D mEPSCs L2/3 FS Inhibitory Neurons C57BL/6J 
    ~P80 
     WT m-/p+ p value 
   neuron number 13 12   
   Cm (pF) 58±3.2 60±3.7 0.756 
   Rs (MΩ) 21±0.9 20±1.2 0.492 
   Rm (MΩ) 84±5.0 81±4.4 0.698 
   Tau (ms) .865±0.05 .884±0.04 0.778 
   
       From Fig. 2.4A mIPSCs L5/6 FS Inhibitory Neurons C57BL/6J 
    ~P80 
     WT m-/p+ p value 
   neuron number 13 14   
   Cm (pF) 39±2.5 36±2.8 0.454 
   Rs (MΩ) 28±1.0 30±0.9 0.226 
   Rm (MΩ) 185±36.2 177±17.7 0.805 
   Tau (ms) .702±0.07 .745±0.03 0.654 
   
       
 
From Fig. 2.4B mEPSCs L5/6 FS inhibitory Neurons C57BL/6J 
    ~P80 
     WT m-/p+ p value 
   neuron number 8 7   
   Cm (pF) 42±4.3 34±2.4 0.136 
   Rs (MΩ) 26±2.5 27±1.8 0.599 
   Rm (MΩ) 153±18.3 187±20.4 0.235 
   Tau (ms) .774±0.09 .577±0.11 0.201 
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Table 2.3 Membrane properties from Paired Recordings and Agatoxin  
experiments related to Figure 2.5 and 2.6 
    
       From Fig. 2.5A-F Intrinsic membrane properties from paired recordings 
  ~P80 
    WT m-/p+ 
    L2/3 Pyr. L2/3 FS L2/3 Pyr. L2/3 FS 
  neuron number 36 36 47 47 
  
Vm (mV) -79±1.8 -72±0.9 -81±0.9 -72±0.9 
  
Rm (MΩ) 105±10.9 110±11.1 107±6.9 120±8.1 
  Distance  
51±3.8 68±5.3 
  btwn soma(μm) 
  
       
       From Fig. 2.5G-I Agatoxin eIPSC Recordings 
     ~P80     
     WT m-/p+ p value 
   neuron number 10 10   
   
Cm (pF) 173±10.5 160±10.4 0.423 
   
Rs (MΩ) 12±0.8 12±0.6 0.468 
   
Rm (MΩ) 224±17.6 268±21.6 0.401 
   Tau (ms) 2.1±0.11 2.0±0.16 0.374 
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CHAPTER 3: CIRCUIT AND CELL-TYPE SPECIFIC REQUIREMENTS FOR Ube3a IN 
NEOCORTICAL EXCITATORY/INHIBITORY BALANCE 
3.1 Overview 
 Balanced excitation and inhibition is critical for normal circuit function and 
disruptions in excitation/inhibition (E/I) balance have been shown to exist in many 
neurological disorders.  Recently, we have shown that an Angelman syndrome mouse 
model (Ube3am-/p+) has an E/I imbalance in cortical circuits.  Inhibitory deficits appeared 
to arise from defective presynaptic vesicle cycling resulting in decreased evoked and 
spontaneous neurotransmission.  Defining the neuron class or classes required for the 
resulting imbalance is crucial to our understanding of neural circuit dysfunction in 
Angelman syndrome as well as elucidating the role of Ube3a in different neuronal 
subtypes.  To permit detailed dissection of the role of Ube3a in specific neural circuits 
we generated a conditional Ube3a knockout mouse which allows neuron type-specific 
deletion of Ube3a.  Surprisingly, when we deleted Ube3a in all GABAergic neurons we 
observed none of the synaptic phenotypes observed when Ube3a was deleted from all 
neurons.  Conversely, when we deleted Ube3a from cortical pyramidal neurons we 
observed only defects in evoked inhibition.  Together these findings suggest Ube3a loss 
is required both pre and postsynaptically for several synaptic phenotypes observed in 
AS model mice.  These results were supported by data showing that re-expression of 
Ube3a in GABAergic neurons was sufficient to normalize defects in inhibitory synaptic 
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vesicle cycling but not evoked inhibition.  Intriguingly, Ube3a may be required in only a 
subset of neurons to achieve normal circuit balance.            
3.2 Introduction 
Classical knockout mouse models of genes implicated in human disorders offer 
an excellent opportunity to study human health and disease in an experimentally 
tractable animal.  One such human disorder is Angelman Syndrome (AS), a severe 
genetic neurodevelopmental disorder caused by deletion or mutation of maternally 
inherited UBE3A (Williams et al., 2006).  AS model mice exhibit behavioral changes 
mirroring the hallmarks of the human syndrome including abnormal EEG patterns, 
elevated seizure susceptibility, and difficulty with movement and balance (Jiang et al., 
1998).  This mouse model has allowed insight into the synaptic defects that occur when 
Ube3a is lost in all neurons.  Previous studies have shown that Ube3a is present both 
pre and postsynaptically in excitatory and inhibitory neurons and deletion of Ube3a 
results in defects at excitatory and inhibitory synapses (Dindot et al., 2008; Wallace et 
al., 2012; Yashiro et al., 2009).  These defects have been hypothesized to underlie 
defective circuit function and behavioral abnormalities seen in AS model mice.  
However, difficulties remain in the interpretation of these results as neural circuits and 
synapses exist under strong homeostatic control; therefore, it is often difficult to 
determine the synaptic defects that result directly from loss of a gene and which, if any, 
are induced secondarily as a consequence of altered circuit function (Marder and 
Goaillard, 2006; Turrigiano and Nelson, 2004).  It is of great importance to understand 
the most direct consequences of gene loss as those may be most beneficial targets for 
therapeutic intervention.       
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Here we use electrophysiological, anatomical, and molecular genetic techniques 
to dissect the role of Ube3a loss in specific neuronal classes to synaptic 
pathophysiology.  Using several newly developed conditional Ube3a mouse lines we 
manipulate Ube3a expression in inhibitory and excitatory neurons in the cortex and 
observe differential effects on synaptic transmission.  We observe that deletion of 
Ube3a in all cortical inhibitory neurons is insufficient to produce synaptic defects seen 
when Ube3a is lost in all neurons.  Conversely, deletion of Ube3a in all cortical 
excitatory neurons results in a decrease in evoked inhibition, but not in defects in 
spontaneous excitatory or inhibitory neurotransmission or synaptic recovery from high 
frequency stimulation.  Finally, we show that restoring Ube3a function in only inhibitory 
neurons early in development prevents deficits in recovery from high frequency 
stimulation at inhibitory synapses and normalizes defects in synaptic vesicle cycling.  
Our findings suggest that specific synaptic phenotypes are due to loss of Ube3a from 
specific classes of neurons and that several defects in AS mice may require loss of 
Ube3a both pre and postsynaptically to become manifest.  
3.3 Results 
3.3.1 Generation and validation of Ube3a conditional knockout mouse 
To explore the physiological and anatomical consequences of Ube3a loss in 
specific neuron classes in the brain we developed a conditional Ube3a knockout mouse.  
Using homologous recombination, a targeting vector containing loxP sites flanking exon 
5 of Ube3a replaced the endogenous Ube3a gene creating a Ube3a conditional 
knockout allele (Fig. 3.1A).  Mice carrying the conditional Ube3a allele on the 
maternally inherited chromosome (Ube3aFlox/p+) were alive and fertile and displayed no 
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obvious behavioral abnormalities.  Cortical lysates showed that Ube3a protein isolated 
from Ube3aFlox/p+ mice ran at the same molecular weight as endogenous Ube3a 
indicating that knock-in of the Ube3a conditional allele did not affect Ube3a protein 
weight (Fig. 3.1B).  We then crossed Ube3aFlox/p+ mice to Nestin-Cre mice which 
express Cre in the entire central nervous system from early embryonic development 
(Graus-Porta et al., 2001; Tronche et al., 1999).  We hypothesized that 
Ube3aFlox/p+::Nestin-Cre mice would recapitulate phenotypes observed in Ube3a null 
mice (Ube3am-/p+) and that Ube3aFlox/p+ mice would be identical to controls (wild-type +/- 
Nestin-Cre).  Ube3a protein levels in neocortex of Ube3aFlox/p+ were not different than 
control mice and Ube3aFlox/p+::Nestin-Cre mice expressed similar levels of Ube3a as 
Ube3am-/p+ mice (Fig 3.1C).  To assess synaptic phenotypes in control, Ube3aFlox/p+, and 
Ube3aFlox/p+::Nestin-Cre we performed whole-cell patch clamp electrophysiology on 
acute slices of L2/3 primary visual cortex.  We recorded miniature inhibitory (mIPSCs) in 
L2/3 pyramidal neurons at adult ages (P70-P90) where synaptic phenotypes have been 
shown to exist in Ube3a maternal null mice (Ube3am-/p+) (Wallace et al., 2012).  
Ube3aFlox/p+::Nestin-Cre mice had a significant decrease in mIPSC frequency compared 
to control and Ube3aFlox/p+ mice (Fig. 3.1G) suggesting defects in synaptic transmission 
similar to those observed in Ube3am-/p+ mice.  Ube3aFlox/p+ mice did not show any 
change in mIPSC frequency compared to control mice indicating that Ube3aFlox/p+ mice 
were similar to wild-type mice (Fig. 3.1G).  Interestingly, Ube3aFlox/p+::Nestin-Cre mice 
had a significant decrease in mIPSC amplitude compared to control mice and a strong 
trend for decreased amplitude compared to Ube3aFlox/p+ mice (Fig. 3.1F).  This effect 
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was not observed in Ube3am-/p+ mice (Fig. 2.1) and may indicate a change in GABA 
receptor number, occupancy, or subunit composition.   
As Ube3am-/p+ mice have also been reported to have defects in evoked inhibitory 
neurotransmission, we recorded evoked IPSCs (eIPSCs) (Fig. 3.1H).  
Ube3aFlox/p+::Nestin-Cre mice showed a significant decrease in eIPSC amplitude 
compared to control mice and a strong trend for reduced amplitude compared to 
Ube3aFlox/p+ mice, suggesting Ube3aFlox/p+::Nestin-Cre mice had decreased inhibitory 
synaptic strength (Fig. 3.1J).  In summary, Ube3aFlox/p+::Nestin-Cre mice harboring a 
new conditional Ube3a allele recapitulate the defects in cortical synaptic transmission 
seen in the AS mouse model (Ube3am-/p+).  Furthermore, Ube3aFlox/p+ mice are similar to 
control wild-type mice and serve as an excellent model to dissect cell class specific 
contributions of Ube3a loss to the aforementioned synaptic phenotypes.     
3.3.2 Conditional deletion of Ube3a from all GABAergic inhibitory interneurons 
 Having validated the conditional Ube3a knockout mouse, we investigated the 
effects of Ube3a loss in specific neuron classes to synaptic phenotypes.  We 
hypothesized that Ube3a loss in GABAergic neurons would have effects on inhibitory 
synaptic phenotypes, and Ube3a loss in excitatory pyramidal neurons would have 
effects on excitatory synaptic phenotypes.  We crossed the Ube3aFlox line to a line which 
expresses Cre in almost all GABAergic neurons in the cortex (Gad2-Cre) to investigate 
the effects of Ube3a loss in only GABAergic neurons (Taniguchi et al., 2011).  This 
breeding scheme produced WT (+/- Gad2-Cre), Ube3aFlox/p+, and Ube3aFlox/p+::Gad2-
Cre mice.  Because we saw no differences between the WT (+/- Cre) and Ube3aFlox/p+ 
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mice in the cross with Nestin-Cre (Fig. 3.1), we combined the WT (+/- Gad2-Cre) and 
Ube3aFlox/p+ groups into a single “control” group for remaining experiments.  To compare 
the effects of Ube3a loss in GABAergic neurons we again performed whole cell patch 
clamp recordings in L2/3 pyramidal neurons (Fig. 3.2).  Surprisingly, unlike 
Ube3aFlox/p+::Nestin-cre, Ube3aFlox/p+::Gad2-Cre mice did not show changes in mIPSC or 
mEPSC frequency or amplitude compared to controls (Fig. 3.2A-H).  Defects in evoked 
inhibitory neurotransmission observed in Ube3aFlox/p+::Nestin-Cre mice were also absent 
in Ube3aFlox/p+::Gad2-Cre mice when compared against controls (Fig. 3.2K).  Finally, 
deleting Ube3a in GABAergic neurons was insufficient to produce defects in synaptic 
recovery from high frequency stimuli seen in Ube3am-/p+ mice (Fig. 2.7), as 
Ube3aFlox/p+::Gad2-Cre mice recovered to similar levels as controls following high 
frequency stimulation (Fig. 3.2N).  These results suggest deletion of Ube3a in 
GABAergic neurons alone is not sufficient to produce any of the synaptic phenotypes 
seen when Ube3a is absent from all neurons.   
3.3.3 Conditional deletion of Ube3a from all excitatory pyramidal neurons 
 As deletion of Ube3a from GABAergic neurons was insufficient to produce 
defects in synaptic transmission seen with global Ube3a loss we next sought to delete 
Ube3a from the other major class of neurons in the cortex, pyramidal neurons.  To 
investigate the effects of Ube3a loss in pyramidal neurons, we crossed the Ube3aFlox 
line to the NEX-Cre line which expresses Cre in all cortical pyramidal neurons 
(Goebbels et al., 2006).  Again, we combined WT (+/- NEX-Cre) and Ube3aFlox/p+ into 
one group labeled “control”.  We observed no change in mIPSC or mEPSC frequency or 
amplitude in Ube3aFlox/p+::NEX-Cre mice compared to controls (Fig. 3.3A-H).  However, 
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deleting Ube3a from all excitatory pyramidal neurons was sufficient to produce defects 
in evoked inhibitory neurotransmission as Ube3aFlox/p+::NEX-Cre mice had decreased 
eIPSC amplitude compared to controls (Fig. 3.3K).  Finally, as seen in 
Ube3aFlox/p+::Gad2-Cre mice, Ube3aFlox/p+::NEX-Cre mice recovered from high frequency 
stimuli to similar levels as controls (Fig. 3.3N).  Taken together, data from 
Ube3aFlox/p+::Gad2-Cre and Ube3aFlox/p+::NEX-Cre suggest reductions in mIPSCs and 
mEPSCs may require loss of Ube3a from both GABAergic and pyramidal neurons.  
Also, loss of Ube3a in pyramidal neurons is sufficient to cause decreased eIPSC 
amplitude and loss of Ube3a in GABAergic neurons is not required for this phenotype 
(Fig. 3.2K and 3.3K).  Finally, phenotypes relating to defects in recovery from high 
frequency stimuli likely require Ube3a loss in both presynaptic GABAergic neurons and 
postsynaptic pyramidal neurons.  Therefore, depending on the synaptic phenotype, 
Ube3a loss in pyramidal neurons is either completely sufficient or completely insufficient 
at producing the particular synaptic defect. 
3.3.4 Conditional reinstatement of Ube3a in all GABAergic inhibitory interneurons 
 One interpretation of the negative results presented from the Ube3aFlox/p+::Gad2-
Cre (Fig. 3.2) mouse is that Ube3a loss is required in additional cell types to produce 
the synaptic defects observed when Ube3a is lost globally.  A second interpretation is 
that the Gad2-Cre line did not delete Ube3a early enough in development (E12-E15), 
and therefore missed the key time point to produce phenotypes seen in 
Ube3aFlox/p+::Nestin-Cre mouse line (Fig. 3.1) where Cre is expressed by E11(Graus-
Porta et al., 2001; Taniguchi et al., 2011).  If the second interpretation were correct, 
then we reasoned we would also be unable to recover synaptic phenotypes in a Ube3a 
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null animal by re-expressing Ube3a with the Gad2-Cre line.  To test this we took 
advantage of an additional conditional Ube3a mouse line which contains a STOP 
cassette flanked by loxP sites between exons 3 and 4 of Ube3a (Ube3aSTOP/p+) (Fig. 
3.4-3.7).  Ube3aSTOP/p+ mice do not express Ube3a in the absence of Cre, but when Cre 
is present the STOP cassette is excised and Ube3a is expressed at normal levels.  This 
line was crossed with the Gad2-Cre line to create three genotypic groups, control (WT 
+/- Gad2-Cre), Ube3aSTOP/p+ and Ube3aSTOP/p+::Gad2-Cre.  Histological analysis 
revealed that Cre mediated recombination efficiency was near 100% as almost all 
cortical GABAergic neurons (marked by parvalbumin, calretinin, and somatostatin) 
expressed Ube3a in the Ube3aSTOP/p+::Gad2-Cre mouse, but not in the Ube3aSTOP/p+ 
mice (Fig. 3.4) (Gonchar et al., 2007).  We performed electrophysiological recordings 
and electron microscopy on these groups at adult ages (P70-P90).  We first recorded 
mIPSCs and mEPSCs in L2/3 pyramidal neurons (Fig. 3.5A-H).  Unfortunately, we did 
not observe mPSC defects in Ube3aSTOP/p+ mice (mice that should be similar to Ube3am-
/p+ and Ube3aFlox/p+::Nestin-Cre mice).  Therefore we could not assess the impact of re-
expressing Ube3a in inhibitory neurons on these phenotypes.  We presume that the 
mPSC phenotypes were not present due to a small amount of transcriptional leak 
observed the in Ube3aSTOP/p+ mice (personal communication with Ype Elgersma).  
However, we did observe a significant decrease in eIPSC amplitude in the Ube3aSTOP/p+ 
mice compared to controls (Fig. 3.5K).  Ube3aSTOP/p+::Gad2-Cre mice showed an eIPSC 
amplitude that was intermediate and not significantly different from either the control or 
Ube3aSTOP/p+ mice (Fig. 3.5K).  We then examined synaptic recovery of the eIPSC 
following high frequency stimuli.  Ube3aSTOP/p+ mice showed defects in recovery from 
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high frequency stimuli that was significantly decreased when compared to both control 
and Ube3aSTOP/p+::Gad2-Cre (Fig. 3.5N).  Therefore, re-expression of Ube3a in 
GABAergic neurons was sufficient to normalize defects in recovery from synaptic 
depletion in the Ube3aSTOP/p+ mice.  Our data from the Ube3aSTOP/p+::Gad2-Cre is 
consistent with our results in the Ube3aFlox/p+::NEX-Cre which similarly have Ube3a 
expressed only GABAergic neurons in the cortex and do not show defects in recovery 
from high frequency stimulation.  These data also suggest that the Gad2-Cre line 
expresses Cre early enough in development to ameliorate some GABAergic synaptic 
phenotypes and is unlikely to be the reason synaptic phenotypes are not present in the 
Ube3aFlox/p+::Gad2-Cre line. 
3.3.5 Synaptic vesicle cycling phenotypes following conditional reinstatement of 
Ube3a in all GABAergic inhibitory interneurons 
 In Ube3am-/p+ mice we observed a large increase in clathrin-coated vesicles 
(CCVs) in GABAergic axon terminals (Fig. 2.7) (Wallace et al., 2012).  We posited that 
this was indicative of defective synaptic vesicle recycling and lead to the defects in 
synaptic recovery from high frequency depletion.  Therefore, we hypothesized that 
changes in CCVs would mirror the changes in recovery from high frequency depletion 
we observed in the Ube3aSTOP/p+ mice.  We performed immunogold electron microscopy 
and analyzed GABAergic axon terminals onto soma and dendrites in control, 
Ube3aSTOP/p+, and Ube3aSTOP/p+::Gad2-Cre mice (Fig. 3.6 and 3.7).  Similar to 
Ube3am-/p+ mice we saw a significant increase in CCVs in the Ube3aSTOP/p+ mice 
compared to controls at GABAergic axon terminals onto soma and dendrites, but 
observed no change in terminal area, mitochondrial area, or synaptic vesicle density 
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(Fig. 3.6B-D and 3.7B-D).  Consistent with our electrophysiological findings, we 
observed a normalization of CCV density at GABAergic axon terminals onto both soma 
and dendrites in the Ube3aSTOP/p+::Gad2-Cre mice compared to controls (Fig. 3.6E and 
3.7E).  Therefore, re-expression of Ube3a in GABAergic neurons is sufficient to 
normalize increases in CCVs observed in mice which lack Ube3a from all neurons.  
Increased density of CCVs also tracks well with electrophysiological phenotypes (ie 
recovery from high frequency stimuli).  Paradoxically, it is likely that there is no increase 
in CCV density in Ube3aFlox/p+::Gad2-Cre mice, even though Ube3a is not present in 
GABAergic neurons, because these mice do not show decreased recovery from high 
frequency stimulation.  Rather, it is probable that Ube3a loss is required both pre and 
postsynaptically for the expression of this phenotype.               
3.4 Discussion 
 This work introduces several new conditional Ube3a mouse lines that allow 
detailed dissection of the role of Ube3a in specific neural circuits.  In this study we 
chose to investigate excitatory and inhibitory circuits in the visual cortex and found 
differential effects of conditional Ube3a deletion and reinstatement on excitatory and 
inhibitory synapses.   
We hypothesized that Ube3a loss in GABAergic neurons would have effects on 
one set of synaptic phenotypes, and Ube3a loss in excitatory pyramidal neurons would 
have effects on others.  Our findings suggest that for several synaptic phenotypes 
(mIPSCs and recovery from synaptic depletion) loss of Ube3a both pre and 
postsynaptically is required for the defect to manifest.  Conversely, Ube3a loss in 
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excitatory neurons alone is sufficient for defects in evoked inhibitory neurotransmission.  
Consequently, for the synaptic phenotypes investigated, Ube3a loss in excitatory 
neurons is either completely sufficient for the synaptic phenotype or completely 
insufficient (Fig. 3.3 and 3.5).  Furthermore, Ube3a loss in inhibitory neurons is 
insufficient to produce any of the synaptic phenotypes assayed (Fig. 3.2). 
Previous observations of synaptic phenotypes at GABAergic synapses in 
Ube3am-/p+ mice lead us to conclude that there existed defects in synaptic vesicle 
cycling (Wallace et al., 2012).  Many of the known molecular mechanisms regulating 
vesicle cycling are in the axon terminal (Slepnev and De Camilli, 2000).  As such, we 
expected that Ube3a loss in the GABAergic neurons alone would be sufficient to cause 
synaptic vesicle cycling defects in GABAergic neurons.  Our results indicate that this is 
unlikely to be the case as Ube3a loss in GABAergic neurons in the Ube3aFlox/p+::Gad2-
Cre mice does not result in electrophysiological phenotypes that indicate defects in 
vesicle cycling (Fig 3.2N).  Paradoxically, expressing Ube3a in GABAergic neurons 
alone in the Ube3aSTOP/p+::Gad2-Cre mice prevents defects in synaptic vesicle cycling at 
GABAergic axon terminals (Fig 3.5N).  Together these findings suggest that Ube3a loss 
is required in both the presynaptic GABAergic neuron and the postsynaptic pyramidal 
neuron in order to result in synaptic vesicle cycling defects.  It is also possible, while 
more complex, that Ube3a deficient GABAergic neurons are primed for defects in 
vesicle cycling but dysfunction does not arise until Ube3a loss occurs in pyramidal 
neurons triggering the observed vesicle cycling defect.  More subtle manipulations of 
cell type and number will be required to definitely determine the link between Ube3a 
loss and synaptic vesicle cycling defects. 
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While loss of Ube3a in GABAergic neurons did not result in any synaptic 
phenotype, loss of Ube3a in pyramidal neurons resulted in decreased evoked IPSC 
amplitude (Fig. 3.3K).  Interestingly, decreased eIPSC amplitude occurred in the 
absence of defects in mIPSCs and synaptic vesicle cycling and is most likely due to 
decreased GABA receptors on the postsynaptic pyramidal neuron.  However, because 
mIPSC amplitude is unchanged it is likely that the decrease in GABA receptors occurs 
extrasynaptically and is only evident when GABA is released in large quantities during 
strong stimulation (Ye et al., 2013).  A decrease in extrasynaptic GABA receptor 
function has already been reported in AS model mice in cerebellar granule neurons 
(Egawa et al., 2012).  Also, similar to cerebellar granule neurons L2/3 pyramidal 
neurons express high levels of extrasynaptic GABA receptors (Jang et al., 2013). 
Intriguingly, L2/3 pyramidal neurons have an increased membrane resistance in 
Ube3am-/p+ mice only when GABA receptors are unblocked (Table. 2.1 and 2.2) 
suggesting a decrease in tonically active extrasynaptic GABA receptors.  
Electrophysiology experiments examining extrasynaptic GABA receptor mediated 
currents will be critical to resolve this issue.  It is also of interest to determine if eIPSC 
amplitude defects are cell-autonomous.  This could be addressed by sparsely deleting 
Ube3a from pyramidal neurons and examining eIPSC amplitude in control and Ube3a 
deficient neurons. 
The work presented here provides a general framework for further investigations 
into the synaptic phenotypes resulting from Ube3a loss.  A crucial future experiment will 
be to test for inhibitory synaptic recovery from depletion when Ube3a is lost both pre 
and postsynaptically.  This can be achieved by sparsely deleting Ube3a in pyramidal 
 70 
 
 
neurons in the Ube3aFlox/p+::Gad2-Cre mice and then recording from neighboring 
pyramidal neurons that either express or lack Ube3a while Ube3a is absent from all 
GABAergic neurons.  Sparse expression of Cre in pyramidal neurons can be achieved 
by a perinatal intracerebroventricular injection of AAV-Cre virus or with tamoxifen 
inducible Cre lines that allow sparse activation of Cre (Agarwal et al., 2012; Chakrabarty 
et al., 2013; Madisen et al., 2010).  In these experiments the vast majority of the 
pyramidal neurons will contain Ube3a and we will be able to either rule in or out the 
possibility that GABAergic neurons are primed for, but not expressing, vesicle cycling 
defects.   
In conclusion, our hypothesis that Ube3a loss in inhibitory neurons governed 
inhibitory synaptic phenotypes, and Ube3a loss in excitatory neurons governed 
excitatory synaptic phenotypes, requires modification.  Our data suggest that Ube3a 
loss in multiple cell types (both GABAergic and pyramidal) is required to produce 
several synaptic phenotypes and that deletion of Ube3a in a single neuronal type is 
insufficient for all phenotypes but one.  Finally, we show reinstating Ube3a in a small 
population of neurons (~20% of cortical neurons are GABAergic) was sufficient to 
normalize defects in synaptic vesicle cycling.  Thus, it is tantalizing to speculate that it 
may be sufficient to reinstate Ube3a in only a small population of neurons in order to 
achieve significant behavioral improvement.       
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3.5 Materials and Methods 
3.5.1 Animals 
 Ube3a-deficient (Ube3am-/p+) mice backcrossed onto the C57BL/6J background 
were obtained from Yong-hui Jiang (Duke University).  Gad2-Cre (JAX# 010802) and 
Nestin-Cre (JAX# 003771) mice were on the C57BL/6J background and were obtained 
from The Jackson Laboratory (www.jax.org).  NEX-Cre mice were on the C57BL/6J 
background and originally described by (Goebbels et al., 2006). Ube3aFloxed mice were 
generated at the UNC Animal Models Core on a C57BL/6J background (see below for 
details).  Ube3aStop mice were generously provided by Ype Elgersma on the 129Sv/Pas 
background and were crossed to Gad2-Cre mice to create F2 or F4 hybrid (C57BL/6J / 
129SvPas) mice that were used for Figures 3.4-3.7.  Mice of both genders were used at 
postnatal day (P) 70-90.  Experimental groups were obtained by crossing a paternal-
Flox (or paternal-STOP) heterozygous female (Ube3am+/Flox(or STOP) mice) with a male 
heterozygous for Cre.  Mice were raised on a 12-h light/dark cycle and fed ad libitum.  
All studies were conducted with protocols approved by the University of North Carolina 
at Chapel Hill Animal Care and Use Committee.    
 
Mouse Transgenics 
 The gene targeting construct used for to create the Ube3aFlox allele was 
generated by the trans-NIH Knock-Out Mouse Project (KOMP) and obtained from the 
KOMP Repository (www.komp.org).  Using knockout first technology (Skarnes et al., 
2011) we validated the construct prior to embryonic stem cell culture and gene 
targeting.  Gene targeting, identification of correctly targeted clones, Southern blotting, 
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ES cell blastocyst injections and transfer to pseudopregnant females were performed by 
the UNC Animal Models Core using standard methods (www.med.unc.edu/amc).  
Chimeric pups were identified by coat color and crossed to a mouse line containing Flpe 
recombinase (JAX# 009086) on a C57BL/6J background to remove the gene trap and 
create Ube3aFlox founder mice.        
 
3.5.2 Coronal Slice Preparation 
 Mice (P70-P90) were anesthetized with pentobarbital (40 mg/kg) and, after 
disappearance of corneal reflexes, intracardially perfused with dissection buffer (in mM: 
87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 75 sucrose, 10 dextrose, 1.3 ascorbic 
acid, 7 MgCl2, and 0.5 CaCl2 bubbled with 95% O2-5% CO2).  Brains were then rapidly 
removed and immersed in ice-cold dissection buffer.  The visual cortices were dissected 
and 350 μm coronal slices were prepared using a vibrating microtome (Leica VT1200s).   
Slices were allowed to recover for 20 min in a 35º C submersion chamber filled with 
oxygenated artificial cerebrospinal fluid (ACSF) (in mM; 124 NaCl, 3 KCl, 1.25 
NaH2PO4, 26 NaHCO3, 1 MgCl2 2 CaCl2 and 20 glucose) and then kept at room 
temperature for >40 min until use (Philpot et al., 2003). 
 
3.5.3 Voltage-clamp Recordings 
 To isolate miniature inhibitory postsynaptic currents (mIPSCs), slices were 
placed in a submersion chamber, maintained at 30º C and perfused at 2 ml/min with 
oxygenated ACSF (as described above) containing (in µM): 20 6,7-dinitroquinoxaline-
2,3-dione (DNQX), 100 D,L-2-amino-5-phosphonopentanoic acid (APV), and 1.0 
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tetrodotoxin (TTX).  L2/3 pyramidal neurons between 20-150 µm ventral from the L1-2 
boundary were targeted for recording.  Cells were visualized using a Ziess Axioskop 
microscope equipped with infrared differential interference contrast (IR-DIC) optics.  
Patch pipettes were pulled from thick-walled borosilicate glass (P2000, Sutter 
Instruments Novato, CA).  Open tip resistances were between 2-5 MΩ when pipettes 
were filled with the internal solution containing (in mM): 100 CsCH3SO3, 15 CsCl, 2.5 
MgCl2, 5 Cs-Bapta, 4 Mg-ATP, 0.3 Na-GTP, 10 HEPES, 5 QX-314-Cl, and 0.025 Alexa- 
568 with pH adjusted to 7.25 with 1M CsOH and osmolarity adjusted to ~295 mOsm by 
addition of sucrose.  Voltage-clamp recordings were performed at 0 mV in the whole-
cell configuration using patch-clamp amplifier (Multiclamp 700A, Molecular Devices), 
and data were acquired at 10 kHz filtered at 2 kHz and analyzed using pClamp 10.2 
(Molecular Devices) and MATLAB (Mathworks) software.  Pipette seal resistances were 
> 1 GΩ, and pipette capacitive transients were minimized prior to breakthrough.  
Changes in series and input resistance were monitored throughout the experiment by 
giving test pulse every 30 s and measuring the amplitude of the capacitive current.  
Cells were discarded if series resistance or input resistance changed by >25%.   
 For evoked IPSCs, the internal solution was identical to the solution used for 
mIPSCs.  The ASCF was identical to solution described above, but tetrodotoxin was not 
added.  IPSCs were evoked from a stimulating electrode (concentric bipolar; 200 μM tip 
separation) placed in 150 μm ventral of the recorded neuron, and stimulation was 
delivered for 200 μs.        
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 mEPSCs were recorded at -70 mV in ACSF containing (in µM) 1.0 TTX, 100 
APV, and 50 picrotoxin.  The internal solution was identical to the solution used for 
mIPSCs.  
 
3.5.4 Western Blotting. 
 Mice were deeply anesthetized with sodium pentobarbital (60 mg/kg i.p.) prior to 
decapitation and brain removal.  The neocortical hemispheres from each harvested 
brain were rapidly dissected in ice-cold PBS and then immediately snap-frozen with 
liquid nitrogen and stored at -80°C.  Frozen tissue samples were homogenized in a 
glass tissue homogenizer (Wheaton, Millville, NJ, USA) with ice-cold RIPA buffer (50 
mM Tris pH 8.0, 150 mM NaCl, 1% triton x-100, 0.1% SDS, 0.5% Na Deoxycholate) 
supplemented with 2 mM EDTA and a protease inhibitor cocktail (Sigma, Saint Louis, 
MO, USA).  Tissue homogenates were cleared by 16,000 x g centrifugation for 20 
minutes at 4°C and protein concentrations of the supernatants were determined using 
the BCA assay (Thermo Scientific).  Protein samples (30 µg per lane) were resolved by 
SDS-PAGE and transferred to nitrocellulose membranes.  Membranes were blocked for 
1 hour at room temperature in Odyssey blocking buffer (Li-COR, Lincoln, NE, USA) 
prior to incubation overnight at 4°C with primary antibodies diluted in a 1:1 solution of 
blocking buffer and Tris-buffered saline containing 0.1% Tween-20 (TBS-Tween).  The 
following primary antibodies were used mouse anti-Ube3a 1:1000 (Sigma) and mouse 
anti-Gapdh (Millipore).  Membranes were subsequently washed repeatedly with TBS-
Tween prior to incubation for 1 hour at room temperature with secondary antibodies 
prepared in the same diluent as the primary antibodies.  The following secondary 
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antibodies were used: 1:10,000 donkey anti-mouse 800CW (LICOR, 926-32212).  
Finally, blots were washed repeatedly in TBS-Tween followed by TBS alone prior to 
imaging with the Odyssey imaging system (LI-COR). 
 
3.5.5 Immunohistochemistry 
Light Microscopy 
 Histology was performed on visual cortices of ~P80 mice that were intracardially 
perfused with ~80 mL of 4% paraformaldehyde (PB, 0.1 M, pH 6.8) and sliced sagitally 
at 40-60 µm on a freezing sliding microtome (Ziess HM430).  Slices were then washed 
in 0.1 M PBS, permeabilized in 0.2% Triton-X and blocked in 5% normal goat serum.  
Primary antibodies were incubated 48hrs at 4⁰C at the following concentrations: mouse 
anti-Ube3a 1:750 (Sigma), rabbit anti-parvalbumin 1:500 (Swant), rabbit anti-calretinin 
1:1000 (Swant), rabbit anti-somatostatin 1:1000 (Peninsula, Cat# T-4103).  Secondary 
antibodies were incubated at 1:500 for 1 hr at room temp and tissue was mounted on 
slides.  Primary visual cortex (layers 1-6) was imaged on a Zeiss LSM 710 Confocal 
Microscope using 20×/0.8 NA objective. 
 
Electron Microscopy 
 Mice were intracardially perfused with 0.9% saline solution for 1 min, followed by 
a mixture of depolymerized 2% paraformaldehyde and 2% glutaraldehyde (Electron 
Microscopy Science) in 0.1 M phosphate buffer, pH 6.8.  Brains were removed and 
postfixed overnight in the same fixative. 50 µm-thick sections were cut on a Vibratome, 
incubated 1 hr in 1% osmium tetroxide in 0.1 M phosphate buffer (pH 6.8), rinsed in 0.1 
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M maleate buffer (pH 6.0), and incubated in 1% uranyl acetate in maleate. Sections 
were dehydrated in ethanol, infiltrated with Spurr resin, and flat-embedded between 
sheets of ACLAR plastic.  Chips of tissue were cut from heat-polymerized wafers and 
glued to plastic blocks; thin (~70 nm) sections were collected on copper mesh grids and 
poststained with uranyl acetate and Sato’s lead.  
 Postembedding immunocytochemistry was performed as previously described 
(Phend et al., 1992).  Nickel grids were pre-treated using 0.01M citrate buffer (pH 6, at 
60°C for 15 mins) and blocked in 1% bovine serum albumin in Tris-buffered saline with 
0.005% Tergitol NP-10 (TBSN, pH 7.6), then incubated overnight at 21–24 °C with the 
rabbit anti-GABA antibody (Sigma, A2052, 1:100,000). Grids were rinsed, blocked in 1% 
normal goat serum in TBSN (pH 8.2), and incubated in goat anti-rabbit conjugated to 20 
nm gold particles (BBI, EM.GAR20) for 2 h, rinsed, then counterstained with 1% uranyl 
acetate followed by Sato's lead.  Electron micrographs were collected with a Philips 
Tecnai microscope at 80 KV. 
Analysis 
 Inhibitory presynaptic terminals from three mice per genotype were analyzed (at 
least 20 terminals per animal for each class).  Inhibitory terminals were identified by 
GABA staining.   
 Parameters measured included cross-sectional area of the presynaptic terminal 
and mitochondria within, number of synaptic vesicles, and number of clathrin-coated 
vesicles.  All morphometric analyses were performed by an anatomist blinded with 
respect to genotype.  
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3.5.6 Statistics 
 All experiments and analyses were performed blind to genotype.  One way 
ANOVA was used to test for significance for mIPSCs, mEPSCs, and changes in CCV 
density in Fig. 3.1, 3.5, 3.6, and 3.7.  Unpaired t-tests were used in for mIPSCs and 
mEPSCs in Fig 3.2 and 3.3.  For eIPSC, depletion, and recovery analyses we employed 
a 2-way ANOVA to assess significance.  Graphs represent the mean and error bars 
represent the SEM.  For all figures p-values are as follows *p<0.05, **p<0.01, 
***p<0.001.  All statistics were performed in Graphpad Prism 6.  
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Figure 3.1 Generation and validation of conditional Ube3a knockout mice.   
(A) Schematic (not to scale) depicting the Ube3aFlox knock-in allele, which can be 
conditionally deleted via Cre/loxP recombination of exon 5.  (B) Western blot of 
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neocortical lysates prepared from control (Ube3am+/p+), maternal floxed mice 
(Ube3aFlox/p+), maternal floxed mice crossed to Nestin-Cre (Ube3aFlox/p+::Nestin-Cre), 
and maternal null mice (Ube3am-/p+).  Gapdh serves as a control for equal protein 
loading.  (C) Quantified protein levels for different mouse lines shown in (B), 
(Ube3am+/p+ n=3, Ube3aFlox/p+ n=5, Ube3aFlox/p+::Nestin-Cre n=6, and Ube3am-/p+ n=2 
animals).  (D) Sample recordings and (E) recording configuration for mIPSCs from 
control, Ube3aFlox/p+ and Ube3aFlox/p+::Nestin-Cre mice (scale bar = 20 pA, 200 ms).  
Average mIPSC (F) amplitude and (G) frequency from control, Ube3aFlox/p+ and 
Ube3aFlox/p+::Nestin-Cre mice (control n=24 cells; Ube3aFlox/p+ n=20 cells; 
Ube3aFlox/p+::Nestin-Cre n=27 cells) in L2/3 pyramidal cells.  (H) Illustration of 
stimulation and recording (L2/3 pyramidal neuron) configuration in primary visual cortex, 
and sample recordings (I) of evoked IPSCs at stimulation intensities of 10, 20, and 100 
µA (scale bar = 1000 pA, 60 ms).  (J) Evoked IPSCs are decreased in Ube3aFlox/p+ :: 
Nestin-Cre mice compared to controls, but Ube3aFlox/p mice are not different from 
controls or Ube3aSTOP/p+ ::Nestin-Cre mice (control n=22 cells; Ube3aFlox/p+ n=16 cells; 
Ube3aFlox/p+::Nestin-Cre n=33 cells).  All data are represented as the mean ± SEM 
(*p<0.05, ***p<.001). 
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Figure 3.2 Lack of synaptic phenotypes in Ube3aFlox/p+::Gad2-Cre mice  
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(A) Recording configuration for mIPSCs, and (B) sample recordings from control and 
Ube3aFlox/p+::Gad2-Cre mice (scale bar = 20 pA, 200 ms).  Average mIPSC (C) 
amplitude and (D) frequency was similar between control and Ube3aFlox/p+::Gad2-Cre 
mice (control n=11 cells; Ube3aFlox/p+::Gad2-Cre n=17) in L2/3 pyramidal cells.  (E) 
Recording configuration for mEPSCs, and (F) sample recordings from control and 
Ube3aFlox/p+::Gad2-Cre mice (scale bar = 20 pA, 200 ms).  Average mEPSC (G) 
amplitude and (H) frequency was similar between control and Ube3aFlox/p+::Gad2-Cre 
mice (control n=19 cells; Ube3aFlox/p+::Gad2-Cre n=14) in L2/3 pyramidal cells.  (I) 
Illustration of stimulation and recording (L2/3 pyramidal neuron) configuration in primary 
visual cortex, and sample recordings (J) of evoked IPSCs at stimulation intensities of 0, 
10, 20, and 100 µA (scale bar = 1000 pA, 60 ms).  (K) Evoked IPSCs are similar 
between control and Ube3aFlox/p+::Gad2-Cre mice (control n=12 cells; 
Ube3aFlox/p+::Gad2-Cre n=11).  (L) Sample recordings showing baseline (top), high 
frequency depletion (middle), and recovery (bottom) phases (scale bars; baseline = 200 
pA, 20 ms; depletion = 200 pA, 70 ms; recovery = 200 pA, 20 ms).  (M) Average 
depletion phase showing eIPSC amplitude normalized to baseline during 800 stimuli at 
30 Hz.  10 responses are averaged for each point (control n=11; Ube3aFlox/p+::Gad2-Cre 
n=9).  (N) Average recovery phase showing eIPSC amplitude normalized to baseline 
during 90 stimuli at 0.33 Hz.  3 responses are averaged for each point (control n=11; 
Ube3aFlox/p+::Gad2-Cre n=9).  All data are represented as the mean ± SEM.   
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Figure 3.3 Loss of Ube3a in cortical pyramidal neurons in Ube3aFlox/p+::NEX-Cre 
mice is sufficient for some, but not all synaptic phenotypes.  
(A) Recording configuration for mIPSCs, and (B) sample recordings from control and 
Ube3aFlox/p+::NEX-Cre mice (scale bar = 20 pA, 200 ms).  Average mIPSC (C) amplitude 
and (D) frequency was similar between control and Ube3aFlox/p+::NEX-Cre mice (control 
n=15 cells; Ube3aFlox/p+::NEX-Cre n=11) in L2/3 pyramidal cells.  (E) Recording 
configuration for mEPSCs, and (F) sample recordings from control and 
Ube3aFlox/p+::NEX-Cre mice (scale bar = 20 pA, 200 ms).  Average mEPSC (G) 
amplitude and (H) frequency was similar between control and Ube3aFlox/p+::NEX-Cre 
mice (control n=14 cells; Ube3aFlox/p+::NEX-Cre n=15) in L2/3 pyramidal cells.  (I) 
Illustration of stimulation and recording (L2/3 pyramidal neuron) configuration in primary 
visual cortex, and sample recordings (J) of evoked IPSCs at stimulation intensities of 0, 
10, 20, and 100 µA (scale bar = 1000 pA, 60 ms).  (K) Evoked IPSC amplitude is 
decreased in Ube3aFlox/p+::NEX-Cre mice compared to controls (control n=14 cells; 
Ube3aFlox/p+::NEX-Cre n=22).  (L) Sample recordings showing baseline (top), high 
frequency depletion (middle), and recovery (bottom) phases (scale bars; baseline = 200 
pA, 20 ms; depletion = 200 pA, 70 ms; recovery = 200 pA, 20 ms).  (M) Average 
depletion phase showing eIPSC amplitude normalized to baseline during 800 stimuli at 
30 Hz.  10 responses are averaged for each point (control n=11; Ube3aFlox/p+::NEX-Cre 
n=16).  (N) Average recovery phase showing eIPSC amplitude normalized to baseline 
during 90 stimuli at 0.33 Hz.  3 responses are averaged for each point (control n=11; 
Ube3aFlox/p+::NEX-Cre n=16).  All data are represented as the mean ± SEM (*p<0.05).   
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Figure 3.4 Highly efficient Cre mediated maternal Ube3a reinstatement across 
interneuron subclasses in Ube3Stop/p+::Gad2-Cre mice. 
(A-C) Co-immunohistochemical staining for parvalbumin (PV) and Ube3a in layer 2/3 
visual cortex of control (A1-3), Ube3a
Stop/p+ (B1-3), and Ube3a
Stop/p+::Gad2-Cre (C1-3).  (D) 
Quantification of Ube3a coexpression in PV+ interneurons across all cortical layers.  
Values represent the mean percentage of coexpression for individual animals (n=5 
animals per genotype).  (E-G) Co-immunohistochemical staining for calretinin (CR) and 
Ube3a in layer 2/3 visual cortex of control (E1-3), Ube3a
Stop/p+ (F1-3), and 
Ube3aStop/p+::Gad2-Cre (G1-3).  (H) Quantification of Ube3a coexpression in CR
+ 
interneurons across all cortical layers (n=5 animals per genotype).    (I-K) Co-
immunohistochemical staining for somatostatin (SST) and Ube3a in layer 2/3 visual 
cortex of control (I1-3), Ube3a
Stop/p+ (J1-3), and Ube3a
Stop/p+::Gad2-Cre (K1-3).  (L) 
Quantification of Ube3a coexpression in SST+ interneurons across all cortical layers 
(n=5 animals for control and Ube3aStop/p+::Gad2-Cre and 4 animals for Ube3aStop/p+).  
Animal averages ± SEM are indicated.  Scale bar = 75 µm.  
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Figure 3.5 Reinstatement of Ube3a in GABAergic neurons in Ube3aSTOP/p+::Gad2-
Cre mice restores defects synaptic recovery.   
(A) Sample recordings and (B) recording configuration for mIPSCs from control, 
Ube3aSTOP/p+ and Ube3aSTOP/p+::Gad2-Cre mice (scale bar = 20 pA, 200 ms).  Average 
mIPSC (C) amplitude and (D) frequency was similar between control, Ube3aSTOP/p+ and 
Ube3aSTOP/p+::Gad2-Cre mice (control n=43 cells; Ube3aSTOP/p+ n=34 cells; 
Ube3aSTOP/p+::Gad2-Cre n=30 cells) in L2/3 pyramidal cells.  (E) Sample recordings and 
(F) recording configuration for mEPSCs from control, Ube3aSTOP/p+ and 
Ube3aSTOP/p+::Gad2-Cre mice (scale bar = 20 pA, 200 ms).  Average mEPSC (G) 
amplitude and (H) frequency was similar between control, Ube3aSTOP/p+ and 
Ube3aSTOP/p+::Gad2-Cre mice (control n=19 cells; Ube3aSTOP/p+ n=22 cells; 
Ube3aSTOP/p+::Gad2-Cre n=19 cells) in L2/3 pyramidal cells. (I) Illustration of stimulation 
and recording (L2/3 pyramidal neuron) configuration in primary visual cortex, and 
sample recordings (J) of evoked IPSCs at stimulation intensities of 0, 10, 20, and 100 
µA (scale bar = 1000 pA, 60 ms).  (K) Evoked IPSCs are decreased in Ube3aSTOP/p+ 
mice compared to controls, but Ube3aSTOP/p+::Gad2-Cre mice are not different from 
controls or Ube3aSTOP/p+ mice (control n=21 cells; Ube3aSTOP/p+ n=24 cells; 
Ube3aSTOP/p+::Gad2-Cre n=29 cells).  (L) Sample recordings showing baseline (top), 
high frequency depletion (middle), and recovery (bottom) phases (scale bars; baseline = 
200 pA, 20 ms; depletion = 200 pA, 70 ms; recovery = 200 pA, 20 ms).  (M) Average 
depletion phase showing eIPSC amplitude normalized to baseline during 800 stimuli at 
30 Hz.  10 responses are averaged for each point (control n=9 cells; Ube3aSTOP/p+ n=13 
cells; Ube3aSTOP/p+::Gad2-Cre n=11 cells).  (N) Average recovery phase showing eIPSC 
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amplitude normalized to baseline during 90 stimuli at 0.33 Hz.  3 responses are 
averaged for each point (control n=9 cells; Ube3aSTOP/p+ n=13 cells; 
Ube3aSTOP/p+::Gad2-Cre n=11 cells).  All data are represented as the mean ± SEM 
(*p<0.05; **p<.01).   
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Figure 3.6 Accumulation of CCVs in Ube3aSTOP/p+ mice at inhibitory synapses onto 
somata are eliminated by reinstatement of Ube3a in inhibitory interneurons.  
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(A) Electron micrographs of inhibitory synapses stained for GABA in control, 
Ube3aSTOP/p+, and Ube3aSTOP/p+::GAD2-Cre mice (green denotes axon terminal, blue 
denotes soma, arrows indicate CCVs).  Average values of (top to bottom) (B) axon 
terminal area, (C) mitochondrial area, (D) number of synaptic vesicles (SV) per square 
micron, and (E) number of CCVs per square micron (****p<0.0001, n = 3 animals per 
genotype). 
 
 
 
 
 
 
 
 
 
 
 
 
 91 
 
 
 
Figure 3.7 Accumulation of CCVs in Ube3aSTOP/p+ mice at inhibitory synapses onto 
dendrites are eliminated by reinstatement of Ube3a in inhibitory interneurons.  
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(A) Electron micrographs of inhibitory synapses stained for GABA in control, 
Ube3aSTOP/p+, and Ube3aSTOP/p+::GAD2-Cre mice (green denotes axon terminal, red 
denotes dendrite, arrows indicate CCVs).  Average values of (top to bottom) (B) axon 
terminal area, (C) mitochondrial area, (D) number of synaptic vesicles (SV) per square 
micron, and (E) number of CCVs per square micron (****p<0.0001, n = 3 animals per 
genotype). 
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CHAPTER 4: DISCUSSION 
4.1 Molecular mechanisms underlying synaptic defects in AS model mice 
 Ube3a is an E3 ubiquitin ligase and its primary function is to transfer polyubiquitin 
chains to substrate proteins targeting them for proteasomal degradation.  Therefore, it 
has been hypothesized that AS results from the accumulation of Ube3a substrate 
proteins which in turn cause cellular/circuit dysfunction and behavioral abnormalities.  
However, identifying molecular targets for Ube3a in neurons has been one of the 
greatest challenges to AS research.  Only recently have targets for Ube3a been 
identified that have a direct link to synaptic transmission.  Notably, Arc and Ephexin5, 
which possibly contribute to defects in excitatory neurotransmission and plasticity, were 
recently identified as Ube3a substrates (Greer et al., 2010; Margolis et al., 2010).   
 Activity-regulated cytoskeleton-associated protein (Arc) is involved in regulation 
of excitatory synaptic strength through its actions during activity regulated AMPA 
receptor endocytosis (Chowdhury et al., 2006).  In Ube3am-/p+ mice, Arc protein levels 
are increased and it has been shown that Ube3a interacts with a fragment of the Arc C-
terminus in vitro.  Therefore, it has been hypothesized that Arc is a substrate that Ube3a 
targets for degradation and accumulates in the absence of Ube3a resulting in excessive 
AMPA receptor endocytosis and excitatory synapse loss ((Greer et al., 2010), but also 
see (Kuhnle et al., 2013)).  However, Arc is also strongly regulated by neuronal activity 
levels and could be expressed at increased levels in the seizure prone Ube3am-/p+ mice 
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(Lyford et al., 1995).  Furthermore, Arc levels have been shown to be increased in other 
mouse models of autism spectrum disorders as a byproduct of increased neuronal 
activity levels rather than a direct consequence of gene loss (Bateup et al., 2013).  If Arc 
is in fact a true substrate of Ube3a than mosaic deletion of Ube3a may result in cell 
autonomous loss of excitatory synapses, a hypothesis that will be tested in the future.  
Despite the advances made in understanding the molecular underpinnings of excitatory 
synaptic defects in Ube3am-/p+ mice, no study has uncovered any potential Ube3a 
substrates involved in inhibitory synaptic function.   
 The molecular architecture involved in synaptic vesicle recycling has been 
studied extensively and has revealed a detailed interplay between large numbers of 
presynaptic proteins (Slepnev and De Camilli, 2000; Sudhof, 2004).  Therefore, when 
we observed an increase in CCVs in the presynaptic terminals of inhibitory synapses in 
Ube3am-/p+ mice we were able to quickly identify key molecules known to be involved in 
clathrin-coated vesicle formation and uncoating.  Synaptojanin 1 was identified as a 
molecule necessary for the uncoating of CCVs.  Its phosphoinositide phosphatase 
activity initiates disassembly of the clathrin coat, and it has also been shown to be 
involved in the early stages of CCV endocytosis (Cremona et al., 1999; Mani et al., 
2007).  Interestingly, inhibitory axon terminals seem to be particularly sensitive to insults 
to synaptic vesicle cycling machinery perhaps due to their high probability of release, 
low synaptic vesicle number, and/or high activity rates (Hayashi et al., 2008; Luthi et al., 
2001).  Neurons and mice lacking synaptojanin 1 accumulate large numbers of CCVs, 
especially at inhibitory synapses, and have defects in recovery of neurotransmission 
following high frequency stimulation (Cremona et al., 1999; Hayashi et al., 2008).  
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Similar to synaptojanin 1 KOs, Ube3am-/p+ mice have no detectable defects in baseline 
synaptic release probability; however, following periods of high activity GABA release is 
reduced (Fig. 2.7C3).  Reduced GABA release following high levels of activity is likely 
due to defective replenishment of release competent synaptic vesicles subsequent to 
deficient synaptic vesicle recycling (Kim et al., 2002).        
 Other proteins involved in synaptic vesicle cycling have been shown to directly 
associate with synaptojanin 1, these include endophillin, Eps15, syndapin and 
amphiphysin (Di Paolo et al., 2002; Koh et al., 2007; Milosevic et al., 2011; Qualmann et 
al., 1999).  Of this group, endophillin was recently shown to be required for uncoating of 
CCVs, and endophillin KO neurons have a similar electrophysiological signature as both 
synaptojanin 1 KOs and Ube3am-/p+ mice (Milosevic et al., 2011).  While these mice 
show similar phenotypes to Ube3am-/p+ mice, it is unlikely that Ube3a directly targets any 
of these proteins for degradation because deletion, not overexpression, of these 
molecules leads to phenotypes similar to Ube3am-/p+ mice.  It is more likely that Ube3a 
targets a negative regulator of a protein required for CCV uncoating or alternatively 
activates a protein required for CCV uncoating, resulting in CCV accumulation in the 
absence of Ube3a.   
 Monoubiquitination is also performed by E3 ubiquitin ligases such as Ube3a and 
is a reversible non-proteolytic modification and that controls protein function (Haglund 
and Dikic, 2005).  Interestingly, monoubiquitination of endocytic proteins Eps15 and 
Epsin is important for their functional roles and interactions with other endocytic/CCV 
associated proteins (Chen et al., 1998; Koh et al., 2007; Polo et al., 2002).  In fact, a 
small 40 aa protein domain is required for their monoubiquitination and is present on 
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several other proteins involved in membrane trafficking at the axon terminal (Polo et al., 
2002).  Therefore, proteins involved in synaptic vesicle cycling/membrane trafficking 
may be particularly vulnerable to defects in monoubiquitination resulting from Ube3a 
loss.  Additionally, there has recently been evidence that Ube3a has a role in the golgi 
apparatus and membrane trafficking further implicating vesicle and membrane 
trafficking in AS pathology (Condon et al., 2013).   
 Collectively, there is strong evidence that inhibitory synapses in Ube3am-/p+ mice 
have vesicle cycling and/or CCV uncoating defects.  Furthermore, several proteins 
involved in clathrin-coated vesicle endocytosis and uncoating are targets for 
ubiquitination and, when deleted, lead to synaptic phenotypes similar to those observed 
in Ube3am-/p+ mice.  Future biochemical and proteomic studies examining levels of CCV 
associated proteins, and their ubiquitination status, at inhibitory axon terminals in 
Ube3am-/p+ mice will yield important insights into new substrates for Ube3a.    
4.2 GABAA receptor contributions to inhibitory defects in AS model mice 
 GABAA receptors (GABARs) have long been hypothesized to be involved in AS 
pathogenesis due to the proximity of UBE3A to a cluster of GABAR subunit genes (β3, 
α5, and γ3) on chromosome 15 (Dan and Boyd, 2003).  Therefore it was predicted that 
haploinsufficency of a GABARs in large deletion patients may contribute to certain AS 
symptoms.  This hypothesis has received less attention in studies on the AS mouse 
model as the targeted mutation is in the Ube3a gene alone and does not disrupt genes 
coding for GABAR subunits.  However, there are reports of reduced GABAR subunit α5 
mRNA levels in the cerebellum of Ube3am-/p+ mice indicating reduced Ube3a levels may 
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affect select GABAR subunits (Low and Chen, 2010).  Nevertheless, to date, no study 
has revealed decreased GABA receptor protein levels in AS model mice.      
 Our studies performed in the Ube3am-/p+ mice led us to believe that defects in 
GABAergic neurotransmission were primarily presynaptic, arising from defects in 
synaptic vesicle cycling.  Furthermore we observed no change in mIPSC amplitude 
indicating that activation of synaptic GABARs was unchanged in Ube3am-/p+ mice (Fig. 
2.1).  Therefore, we were surprised to see decreased evoked IPSC amplitude in the 
Ube3aFlox/p+::NEX-Cre mice where Ube3a was deleted in the postsynaptic pyramidal 
neuron but not the presynaptic GABAergic neurons (Fig. 3.3K).  This finding made us 
reconsider the possibility that there were both pre and postsynaptic contributions to 
GABAergic neurotransmission defects in Ube3am-/p+ mice.   
 mIPSC amplitude remains unchanged in Ube3aFlox/p+::NEX-Cre mice, therefore it 
is likely that a reduction in extrasynaptic GABARs are contributing to decreased evoked 
IPSC amplitude which are activated during high stimulation intensities (Brickley and 
Mody, 2012).  Extrasynaptic, primarily δ-subunit containing, GABARs have a high 
affinity for GABA and are tonically activated by the low concentrations of ambient GABA 
present in the extracellular space (Farrant and Nusser, 2005).  Recent studies 
examining cerebellar granule neurons observed decreased tonic GABA current in 
Ube3am-/p+ mice due to decreased extracellular GABA concentrations.  GABA 
concentrations were decreased due to increased expression of the GABA transporter 
GAT1 in Ube3am-/p+ mice (Egawa et al., 2012).  It is likely that alterations in 
extrasynaptic GABARs also occur in L2/3 pyramidal neurons of Ube3am-/p+ mice; 
however, it is unlikely that changes in tonic GABA current would be due to changes in 
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GAT1 expression in the Ube3aFlox/p+::NEX-Cre mice as Ube3a levels are normal in 
GABAergic neurons and astrocytes that predominantly express GAT1 (Melone et al., 
2013; Minelli et al., 1995).  Furthermore, changes in extrasynaptic GABARs may have 
different effects in L2/3 pyramidal neurons than in cerebellar granule neurons as they 
can be partially activated by synaptic GABA release (Ye et al., 2013).  Studies 
examining extrasynaptic GABARs including investigation of the tonic GABAR current 
will help to determine the precise contribution of extrasynaptic GABARs to defects in 
inhibitory neurotransmission in Ube3am-/p+ mice.  Finally, it will also be important to 
determine if loss of Ube3a in the postsynaptic pyramidal neuron alone is sufficient to 
cell-autonomously decrease evoked IPSC amplitude in L2/3 pyramidal neurons.  This 
can be achieved with mosaic expression of Cre in the Ube3aFlox/p+ mouse line (Agarwal 
et al., 2012; Chakrabarty et al., 2013).  Once cell autonomous phenotypes are 
identified, understanding the molecular and biochemical means by which they result 
from Ube3a loss will allow a more complete picture of Ube3a function in specific neuron 
types and circuits.     
4.3 E/I imbalance and seizure susceptibility in AS 
 Individuals with Angelman syndrome have increased seizure susceptibility and 
often develop epilepsy (Thibert et al., 2009).  Epilepsy in AS patients is notoriously 
difficult to control with treatments often differing largely from patient to patient, and even 
changing drastically within a patient over time (Thibert et al., 2013).  AS patients also 
present with a characteristic electroencephalogram (EEG) signature consisting of 
notched delta (1-3.5 Hz) and rhythmic theta (4-7.5 Hz) activity interspersed with 
epileptiform discharges (Thibert et al., 2009).  Therefore, while seizure genesis may not 
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lie within cortical circuits, they clearly participate and permit seizure activity and 
abnormal cortical oscillations in AS individuals.   
 A major impetus for initiating our studies on E/I balance in Ube3am-/p+ mice were 
reports regarding their high susceptibility to seizures (Jiang et al., 1998).  Seizures in 
Ube3am-/p+ mice are triggered by strong auditory stimuli such as vigorous key grating on 
a metal cage top, or loud (120 dB) personal alarm systems (Jiang et al., 1998; Osterweil 
et al., 2013).  These audiogenic seizures are dependent on mouse strain and are 
present on the 129Sv/Ev or 129Sv/Pas strain, but not the C57BL/6J strain ((Jiang et al., 
1998), unpublished observations).  Audiogenic seizures are a model of generalized 
seizure that involves predominantly midbrain auditory circuits such as the inferior 
colliculus and reticular formation, but also recruit cortical and limbic circuits following 
kindling (Ross and Coleman, 2000; Simler et al., 1994).  It is difficult to speculate on 
how cortical E/I imbalance may relate or contribute to audiogenic seizure susceptibility 
in Ube3am-/p+ mice; however, clearly hyperexcitable circuits do exist in Ube3am-/p+ mice 
and cortical circuits are positioned to propagate epileptic activity throughout the brain.   
 In support of cortical participation in epileptic activity, AS model mice exhibit 
abnormal cortical EEG/ECoG patterns on both 129 and C57 mouse strains (Jiang et al., 
1998; Miura et al., 2002).  Furthermore, detailed power spectral analysis of cortical 
network activity using local field potential (LFP) recordings made from primary visual 
cortex of Ube3am-/p+ mice revealed increased power in the delta and theta frequency 
bands compared to controls (Riday, 2013).  This suggests that aberrant LFP activity in 
Ube3am-/p+ mice may mirror altered EEG activity occurring the same frequency bands in 
AS individuals.  Recent optogenetic studies examining cellular determinants of cortical 
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oscillations have demonstrated that increased power in the low frequency delta and 
theta bands likely arises from increased synchrony of cortical pyramidal neurons 
(Cardin et al., 2009; Vierling-Claassen et al., 2010).  These observations suggest that 
increased pyramidal neuron activity may underlie increased delta and theta power in 
cortical networks of Ube3am-/p+ mice.  It will be interesting to examine cortical 
oscillations in conditional Ube3a animals to test for neuron type-specific contributions to 
abnormal cortical rhythms.          
 While generalized tonic-clonic seizures are the most dangerous type of epileptic 
activity to occur in AS individuals, absence or drop seizures are just as common 
(Thibert et al., 2009).  Absence seizures may arise from disruptions in the 
thalamocortical circuit and are detected with EEG as sudden generalized synchronous 
spike-wave discharges of 2-4 Hz (Genton et al., 2008; Huguenard and McCormick, 
2007).  Absence seizures behaviorally manifest as a loss of cognitive abilities and 
behavioral arrest (Browne et al., 1974).   
 Ube3am-/p+ mice also exhibit spontaneous spike wave discharges that occur with 
behavioral immobility and abnormal posturing (Colas et al., 2005).  It is likely that the 
increased delta and theta power observed in the visual cortex LFP results, at least in 
part, from these spike-wave discharges which may indicate occurrence of absence 
seizures in the AS model mouse.  Spike-wave discharges arise following bursting 
activity of thalamocortical relay neurons which synapse onto layer 4 excitatory neurons 
resulting in high frequency synchronous activity in cortical layers 4 and 2/3 (McCormick 
and Contreras, 2001).  This activity is detected by the EEG electrodes as a large spike 
that repeatedly occurs at 2-4 Hz during an absence seizure (Genton et al., 2008).   
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 The presence of abnormal slow-wave sleep in AS model mice also points 
towards defective thalamocortical circuitry (Colas et al., 2005).  “Sleep spindles” or 
rhythmic thalamocortical bursting events during slow-wave (non-REM) sleep, require 
thalamocortical and GABAergic thalamic reticular circuitry and may underlie abnormal 
sleep in AS mice (Bruni et al., 2004; Colas et al., 2005; Halassa et al., 2011).  Together, 
physiological and behavioral measures in AS model mice present a convincing case for 
the occurrence of absence, thalamocortically derived, seizure activity.  It is possible that 
this activity may arise from defective thalamic, cortical, or thalamocortical circuits.  E/I 
imbalance in cortical circuits could certainly magnify and propagate seizure activity 
initiated in the thalamus, and it is likely that all three circuits have some role in seizure 
activity.  Obviously, experiments directed at monitoring thalamocortical networks and 
behavioral state simultaneously are needed before one can make strong conclusions 
concerning absence seizures, and their underlying circuits, in AS mice.     
4.4 Rescue/prevention of AS phenotypes via expression of Ube3a in GABAergic 
neurons 
 A provocative finding arising for our studies examining Ube3aSTOP/p+ mice were 
that reinstating Ube3a expression in GABAergic neurons in early development 
prevented defects in synaptic vesicle cycling at inhibitory synapses (Fig 3.5-7).  These 
data suggest that reinstating Ube3a in a small subpopulation of neurons may be 
sufficient for significant recovery of circuit function in AS model mice.  Of course, the 
GAD2-Cre line expresses Cre in GABAergic neurons throughout the brain, including 
cortex, striatum, thalamic reticular nucleus, hippocampus, etc., all which may contribute 
to the prevention of synaptic vesicle cycling defects in the cortex of Ube3aSTOP/p+ 
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::GAD2-Cre mice (Taniguchi et al., 2011).  Important future experiments will investigate 
recovery of behavioral defects including seizure susceptibility and motor performance 
following reinstatement of Ube3a in GABAergic neurons.  These experiments will also 
help define behaviors that may be relevant to the anatomical and electrophysiological 
defects we observed in the visual cortex.  Also, crossing the Ube3aSTOP/p+ line to Cre 
lines targeting subsets of GABAergic neurons in specific brain areas (ie cortical, 
thalamic, etc.) will allow further identification of the particular GABAergic circuits that are 
required for rescue of synaptic defects and associated behaviors.   
 Recent studies have shown that the small molecule inhibitors of topoisomerase 
are capable of unsilencing paternal Ube3a in AS mice (Huang et al., 2012).  A 
remaining challenge is to determine the therapeutic window for treatments based on 
reinstating Ube3a expression.  A major advantage of the Ube3aSTOP/p+ line is that Ube3a 
expression of Ube3a can be controlled in a temporally precise and dose dependent 
manner when combined with tamoxifen inducible Cre lines (Hayashi and McMahon, 
2002).  Therefore, to define the most efficacious window(s) for therapeutic intervention, 
one could employ a GABAergic neuron specific inducible Cre line and inject tamoxifen 
at specific points in development, then electrophysiologically and behaviorally assay for 
recovery of AS phenotypes.     
 Identifying optimal windows for therapeutic intervention as well as the neuron 
type or types most likely to yield significant behavioral improvement are crucial future 
studies that will be of large interest in the AS field.  Importantly, many of those future 
experiments rely and build on the work presented here.    
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4.5 Effects of E/I imbalance on cortical computation  
 Synaptic deficits observed in Ube3am-/p+ mice result in cortical E/I imbalance; 
however, it remains unclear how E/I imbalance would affect neuronal computations 
performed in cortex.  Several studies have recently examined the effects of modulating 
inhibition on information transfer within the cortical neural network (Sohal et al., 2009; 
Yizhar et al., 2011).  These studies and others suggest that timing and synchronization 
within and between neural networks is controlled by inhibition and is crucial for efficient 
information processing and transfer (Buzsaki and Watson, 2012).  E/I imbalance in 
Ube3am-/p+ mice likely interferes with optimal information processing in cortical networks 
as evidenced by altered cortical synchrony and cognitive defects (Huang et al., 2013; 
Riday, 2013).   
 A cortical region that allows direct testing for defects in cortical computations is 
the visual cortex, which traditionally has been a focus of many computational 
neuroscientists studying vision and provides a rich literature describing various circuit 
computations (Marr, 1980; Priebe and Ferster, 2012).  Recently, optogenetic modulation 
of inhibition in visual cortex has shown that cortical computations underlying orientation 
tuning and contrast sensitivity can be modified by increasing or decreasing activity of 
entire subpopulations of inhibitory neurons (Atallah et al., 2012; Cottam et al., 2013; Lee 
et al., 2012; Wilson et al., 2012).  By extension, E/I imbalance may be expected to affect 
orientation tuning and contrast sensitivity in visual cortex Ube3am-/p+ mice.  Alternatively, 
defects in inhibition in Ube3am-/p+ mice are quite distinct from optogenetic modulation of 
inhibitory neuron subpopulations and may be expected to have different effects.  For 
example, due to synaptic vesicle cycling defects, deficits in inhibition may be particularly 
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severe in Ube3am-/p+ mice following high levels of inhibitory neuron activity, but very mild 
during quiescent states.  Therefore, cortical computations may only be measurably 
altered in Ube3am-/p+ mice following some sort of priming paradigm that would deplete 
GABAergic transmission or a behavioral state or task that heavily activates inhibitory 
neurons.  Increased cortical activity states are observed during periods of heightened 
awareness or attention and therefore may be preferentially affected in Ube3am-/p+ mice 
(Pinto et al., 2013).  Furthermore, particular inputs into cortex activate specific types of 
inhibitory neurons and computations performed by these networks may be particularly 
impaired in AS mice (Lee et al., 2013; Pi et al., 2013). Experiments addressing cortical 
computations in the visual cortex in vivo in awake animals would be the best way to test 
for defects in information processing in cortical circuits in Ube3am-/p+ mice as well as 
other mouse models of neurodevelopmental disorders.  With the advent of advanced 
imaging and optogenetics combined with mouse models with conditional control of gene 
expression, new insights into neurological disorders and their underlying defects in 
neural information processing will emerge.            
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